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Abstract 
The mammalian gut microbiota is composed of autochthonous species that permanently colonize the host 
intestine, and of allochthonous species that are only transiently able to occupy the intestinal environment. In 
this thesis research, Lactobacillus ruminis and Lactobacillus rhamnosus GG were investigated as paradigms 
for each type of microbe–host interaction, with special emphasis on the in vitro characterization of their 
adaptation factors in the host gastrointestinal tract (GIT).  
As one of the best-characterized probiotics, L. rhamnosus GG is of great interest to researchers and the 
probiotic industry. According to previous genome analyses, L. rhamnosus GG has two pilus operons: spaCBA 
encoding the well-studied SpaCBA pili and spaFED putatively encoding SpaFED pili. However, the 
expression of SpaFED pili in L. rhamnosus GG under laboratory conditions has not thus far been reported. 
Nevertheless, in vivo expression of spaFED cannot be ruled out, either. Therefore, in this study, aimed at 
exploring the role of SpaFED pili in host adhesion and immunomodulatory effects, a nisin-induced expression 
system was used for the generation of SpaFED or SpaF-deleted pili in Lactococcus lactis NZ9000. The results 
revealed that SpaFED pili were essential in mediating lactococcal adhesion to intestinal cell lines (Caco-2 and 
HT-29), to certain extracellular matrix (ECM) proteins, and to porcine mucins, the tip pilin SpaF playing a 
central role as a focal adhesion factor. With regard to immunomodulation, SpaFED pili appeared to dampen 
the immune responses, which was largely attributed to the SpaF pilin, in human embryonic kidney (HEK) 293-
blue cells expressing toll-like receptor (TLR) 2, and in Caco-2 cells. However, while encountering human 
peripheral blood monocyte-derived dendritic cells (moDCs), neither immune response enhancement nor 
immune dampening by SpaFED pili was observed.  
For the autochthonous L. ruminis species, the mammalian GIT is so far the only identified niche. Consistent 
with genomic analyses, transmission electron microscopy (TEM) demonstrated that pili in L. ruminis ATCC 
25644 of human origin consisted of the tip (LrpC), basal (LrpB), and backbone (LrpA) pilins, assembled in a 
pattern similar to that in SpaCBA and SpaFED pili of L. rhamnosus GG. Analogously to dissecting the 
characteristics of SpaFED pili in L. rhamnosus GG, recombinant L. lactis strains were constructed, producing 
either LrpCBA or LrpC-lacking pili of L. ruminis. Recombinant LrpCBA pili mediated lactococcal adherence 
to ECM proteins and intestinal epithelial cells, and also dampened TLR2-dependent NF-κB signaling and IL-
8 production in HEK cells, whereas L. ruminis itself induced evidently elevated immune responses. When 
incubated with Caco-2 cells, L. ruminis and recombinant lactococcal constructs expressing pili with and 
without LrpC pilin lowered IL-8 production. Biofilm formation in L. ruminis was not attributed to LrpCBA 
pili. Subsequently, a novel L. ruminis strain (GRL1172) was isolated from porcine feces and demonstrated to 
be flagellated and piliated. To expand our knowledge of the autochthony-promoting properties of this gut-
dwelling species, we analyzed the abilities of this new isolate and three other L. ruminis strains (a human 
isolate, ATCC 25644, and two bovine isolates, ATCC 27780 and ATCC27781) to adhere to host cells and 
extracellular matrix proteins, to inhibit pathogen binding and growth, to maintain epithelial barrier functions, 
and to modulate immune responses in vitro. The results indicated that the strains shared several characteristics, 
such as binding to ECM proteins and HT-29 cells, inhibition of pathogen adhesion and growth, maintenance 
of epithelial barrier functions in epithelial cells, and activation of innate immune responses to various extents.  
In conclusion, this thesis study demonstrated the adhesiveness of SpaFED and LrpCBA pili, which may 
respectively promote the gut retention of L. rhamnosus GG (in addition to the SpaCBA pili) and of L. ruminis. 
Moreover, pilus-mediated dampening of innate immune responses might be a strategy for these two gut 
bacterial species to induce immune tolerance in the host. Additionally, L. ruminis inhibited enteropathogen 
adhesion and growth, as well as maintained intestinal barrier function, which could be regarded as beneficial 
to the host and which may in turn favor the persistent residence of L. ruminis.  
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1. Introduction 
L. rhamnosus GG, originally isolated from the GIT of a healthy person (Goldin and Gorbach, 1984), 
has been extensively used in the food and pharmacy industries, and its consumption has been reported 
to be associated with several health-promoting effects, such as enhancing the treatment and prevention 
of atopic eczema and diarrhea (Kalliomäki et al., 2001; Kalliomäki et al., 2003; Guarino et al., 2009; 
Hojsak, 2017). Even so, the molecular mechanisms underlying these health benefits are not completely 
understood. L. rhamnosus GG, demonstrated to be a piliated bacterium, has two pilus gene clusters in 
its genome, one including spaCBA and the other including spaFED (Kankainen et al., 2009). SpaCBA 
pili promote strong adhesion to human intestinal epithelial cells and display immunomodulatory effects 
(Lebeer et al., 2012). They are recognized by TLR2, resulting in the activation of the TLR2-dependent 
NF-κB signaling pathway leading to the production of pro- and anti-inflammatory cytokines (von 
Ossowski et al., 2013). In contrast to the well-studied SpaCBA pili, the characteristics of SpaFED pili 
are largely unknown. SpaFED pili appear not to be produced by L. rhamnosus GG under laboratory 
conditions (Reunanen et al., 2012). However, SpaFED pili may be expressed in the host GIT, in a 
similar way as the tight adherence pili IV (TadIV) of Bifidobacterium spp., which are only expressed 
in the murine GIT in vivo and which play a crucial role in the bacterial colonization of the host 
(Motherway et al., 2011). The tip pilin SpaF is the only subunit of SpaFED pili responsible for mucus 
binding, as demonstrated by a study using recombinant SpaFED pilin proteins produced in E. coli (von 
Ossowski et al., 2010). However, little other functional data is presently available regarding spaFED-
encoded pili. Therefore, one aim of this study was to explore the adhesive properties and 
immunomodulatory functions of SpaFED pili to better understand the function of L. rhamnosus GG pili. 
L. ruminis is an autochthonous gut-resident bacterial species in humans as well as many animals (Sharpe 
et al., 1973; Al Jassim, 2003; Yun et al., 2005; O’Donnell et al., 2015). It is the only motile 
autochthonous species of the genus Lactobacillus, which has so far been recorded in the mammalian 
gut (Neville et al., 2012). In comparisons between flagellated strains and their isogenic mutants lacking 
flagella, it has been found that flagella are involved in bacterial binding to mucus (Troge et al., 2012) 
and the intestinal epithelium (Mahajan et al., 2009), and they are thus considered as early colonization 
factors (Rossez et al., 2015). Therefore, being flagellated could be related to the persistent gut 
colonization of L. ruminis. Additionally, L. ruminis exhibits immunomodulatory effects via its flagella 
(Neville et al., 2012) or other unknown factors (Taweechotipatr et al., 2009). Importantly, it can hinder 
the growth of enteropathogens such as vancomycin-resistant enterococci in vitro (Yun et al., 2005) and 
rotavirus in vitro and in vivo (Kang et al., 2015). However, despite many interesting effects, L. ruminis 
has surprisingly been poorly explored functionally, and is thus a much-overlooked and less 
characterized gut commensal bacterial species. In a recent study, a cluster of pilus-related genes, similar 
to those of L. rhamnosus GG, were identified in two L. ruminis strains, ATCC 25644 and ATCC 27782 
(Forde et al., 2011), but to date there has been no report proving pilus gene expression in L. ruminis 
either in vitro or in vivo, or demonstrating the functional characteristics of L. ruminis pili. Analogously 
to the description of SpaCBA pili in L. rhamnosus GG (von Ossowski et al., 2013), one aim of this 
study was to investigate the phenotypic traits, including the adhesive properties and immunomodulatory 
effects, of L. ruminis pili.  
The genomes of a limited number of L. ruminis strains isolated from humans, bovines, equines, and 
pigs have so far been sequenced (Forde et al., 2011; Lee et al., 2011; O’Donnell et al., 2015), and certain 
functional traits (e.g., fermentation patterns, survival capabilities and motility) of different host-sourced 
L. ruminis are known to be strain-specific (O’Donnell et al., 2011; Neville et al., 2012; O’Donnell et 
al., 2015). One aim of this work was to broaden knowledge of the characteristics of L. ruminis species. 
To do this, a novel L. ruminis strain was isolated from porcine feces, and its phenotypic characteristics 
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were dissected in parallel with those of one human and two bovine L. ruminis strains. In addition to 
elucidating the adhesive and immunomodulatory properties, another aim of this study was to analyze 
the effect of L. ruminis cells on epithelial barrier function, as many autochthonous or probiotic 
lactobacilli have been shown to maintain the integrity of the intestinal barrier both in vitro and in vivo, 
and some strains are even able to prevent barrier damage caused by enteropathogens (Roselli et al., 
2007; Johnson-Henry et al., 2008; Karczewski et al., 2010; Liu et al., 2015; Yu et al., 2015). Moreover, 
one further aim of this study was to analyze the interactions between L. ruminis and certain enteric 
pathogens. It has been reported that both strongly (Coconnier et al., 1993; Abedi et al., 2013; Hynönen 
et al., 2014) and poorly (Tuomola et al., 1999; Gueimonde et al., 2006) adhesive lactobacilli can inhibit 
pathogen adhesion to host intestinal epithelial cells or mucus. As L. ruminis is an autochthonous 
member of the gut microbiota, this pathogen inhibition trait could be beneficial for its lifelong 
colonization of the GIT. 
 Literature review 
3 
  
2. Literature review  
2.1 Gut defense systems and homeostasis in mammals   
The mucosal surface of the GIT is constantly exposed to foreign antigens, such as ingested food, drugs, 
and a complex microbial community called the gut microbiota. Although facing variable conditions, 
the mammalian gut is in a stable, healthy, and functional state under most circumstances. This is 
attributed to the intestinal epithelial barrier and the intestinal microbiota, as well as to several 
immunological mechanisms that lead to both the tolerance of harmless antigens (e.g. gut microbiota) 
and immunological defense reactions against pathogens.  
2.1.1 Gut mucosal immunity 
The gut mucosal surface is protected by gut-associated lymphoid tissue (GALT), which is the largest 
immune organ of the body and is composed of secondary lymphoid organs and lymphocytes, as 
presented in Figure 1. Specifically, Peyer’s patches (PPs), the inductive sites for the intestinal immune 
response in the small intestine, are composed of lymphoid follicles and covered by follicle-associated 
epithelium containing specialized intestinal epithelial cells (IECs), called M cells (Nagler-Anderson, 
2001; Jung et al., 2010). M cells deliver antigens from the lumen to antigen-presenting cells such as 
DCs in PPs. Isolated lymphoid follicles (ILFs) are intestinal lymphoid tissues that work as inductive 
sites similar to PPs. The lamina propria (LP), the thin connective tissue layer located beneath the 
epithelium, acts as an immune effector site and has abundant immune cells (Nagler-Anderson, 2001; 
Artis, 2008). Mesenteric lymph nodes (MLNs), another type of immune inductive site, collect lymphatic 
drainage (containing, for example, food antigens and gut-resident microbes) from the LP, PPs, and the 
intestinal mucosa (Macpherson and Smith, 2006; Round and Mazmanian, 2009). Effector T cells are 
also found between the intestinal epithelial cells, where they are referred to as intraepithelial 
lymphocytes (IELs) (Murphy et al., 2008). In response to infection, IELs rapidly release cytokines and 
chemokines, thus eliminating the pathogens (Hayday et al., 2001). 
 
Figure 1. Schematic model of the epithelial barrier and gut-associated lymphoid tissue. LP, lamina 
propria; MLN, mesenteric lymph node; PP, Peyer’s patch; ILF, isolated lymphoid follicle; IEL, 
intraepithelial lymphocyte; MHC I/II, major histocompatibility complex I/II; DC, dendritic cell; MØ, 
macrophage; TCR, T-cell receptor; AMPs; antimicrobial peptides; dimeric-sIgA, dimeric secretory 
Literature review 
4 
 
immunoglobulin A; pIgR, polymeric immunoglobulin receptor; Treg, regulatory T cell; Th, helper T 
cell; TJ, tight junction; AJ, adherens junction; D, desmosome. DCs harboring bacterial antigens from 
PPs and the LP migrate to the MLN and activate naïve T cells (CD8 T cells and CD4 T cells). B cells 
are activated with or without the help of Th cells. Data from Turner, 2009; Murphy et al., 2008; and 
Peterson and Artis, 2014. 
The immune system consists of innate and adaptive immunity. Innate immunity is the first line of 
immune defense, composed of the physical (e.g., skin, epithelia, and mucus) and chemical barriers (e.g., 
acidity of the stomach, lysozyme, and antimicrobial peptides secreted by host cells), innate immune 
cells, and the complement system (Murphy et al., 2008). It distinguishes self from non-self, and is 
immediately activated upon the recognition of foreign antigens through a limited number of pattern 
recognition receptors (PRRs). In contrast, adaptive immunity takes several days to develop after 
pathogenic encounter, and thus generates immunological memory and long-lasting protection, 
dependent on a broad range of rearranged receptors on the surface of B and T lymphocytes (Akira et 
al., 2006).  
Innate immunity 
Cells of intestinal innate immunity include macrophages, DCs, granulocytes (neutrophils, basophils, 
and eosinophils), mast cells, and natural killer (NK) cells. Among these, phagocytes such as 
macrophages, immature DCs, and neutrophils work as the first-line defense to clear foreign antigens. 
They detect bacterial components via their surface receptors, followed by rapidly and efficiently 
engulfing and degrading the microbes that breach the intestinal epithelium (Murphy et al., 2008). After 
encountering antigens, macrophages residing in lymphoid and non-lymphoid tissues (Geissmann et al., 
2010) also release cytokines and chemokines that induce inflammation and recruit other immune cells 
to the infection sites, thus killing the invaders (Galli et al., 2011). DCs, rich in LP and Peyer’s patches, 
are divided into two groups: conventional DCs, which are specialized antigen-presenting cells (APCs), 
and plasmacytoid DCs, which produce virus-induced interferon, but are not as crucial as conventional 
DCs in antigen presentation owing to their inadequate production of major histocompatibility complex 
(MHC) II and costimulatory molecules (Murphy et al., 2008; Reizis et al., 2011).  
Innate immune responses are activated through the recognition of microbe-associated molecular 
patterns (MAMPs) by PRRs expressed on immune cells and intestinal epithelial cells (IECs). PRRs are 
able to detect a wide range of MAMPs shared by both the gut microbiota and the pathogens, such as 
flagellin, lipopolysaccharides (LPS), and pili. TLRs recognizing various bacterial components are 
signaling receptors and among the best characterized PRRs (Eisenbarth and Flavell, 2009). Activation 
of any TLR is able to provoke NF-κB signaling, dependent on adaptor proteins that contribute to the 
signal transduction, such as myeloid differentiation primary response gene 88 (MyD88), TIRAP, and 
TRIF (Kawai and Akira, 2007). In the cytoplasm of inactivated cells, NF-κB is bound to its inhibitor, 
IκB (Figure 2). Upon stimulation, IκB is phosphorylated by its kinase, IKK, resulting in the 
translocation of NF-κB to the nucleus, which then induces the transcription of various cytokine and 
chemokine genes (Tak and Firestein, 2001), and the expression of costimulatory molecules on cells 
such as DCs (Kawai and Akira, 2007). 
An important part of innate immunity is the generation of reactive oxygen species (ROS), in which 
polymorphonuclear leukocytes (e.g. neutrophils) and mononuclear phagocytes (e.g. macrophages) are 
involved (Fang, 2004). Upon bacterial stimulus, ROS production is immediately induced via the 
NADPH phagocyte oxidase-dependent pathway, working as a host defense (Fang, 2004). The roles of 
ROS are versatile and not restricted to the innate immune response: not only do they directly target and 
disrupt microbial DNA, RNA, membranes, and proteins (Cabiscol et al., 2010), but they also regulate 
host immunity. ROS are able to modulate various immune cells, including the induction of maturation 
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of DCs, apoptosis in NK cells, and differentiation of B cells (Hansson et al., 1996; Yang et al., 2013). 
Additionally, ROS help polymorphonuclear leukocytes to migrate and prolong their stay at the infection 
sites, leading to bacterial killing (Nathan and Cunningham-Bussel, 2013). Moreover, ROS play a role 
in signaling that leads to the activation of NF-κB and mitogen-activated protein kinases pathways 
(Hancock et al., 2001; Son et al., 2011).  
Adaptive immunity 
APCs that have taken up antigens either stay in PPs and LPs or migrate to MLNs, as shown in Figure 
1, and then present antigens to naïve lymphocytes (Iwasaki and Medzhitov, 2010; Perez-Lopez et al., 
2016). Both DCs and macrophages work as APCs, but macrophages are not as efficient as DCs (Gordon 
and Taylor, 2005). The naïve T lymphocytes are divided into CD4 and CD8 T cells, and their activation 
is dependent on the antigens and co-stimulatory molecules on APCs. Naïve CD8 T cells detect antigen 
peptides through MHC I molecules on APCs, resulting in cytotoxic T cells that aim at killing infected 
cells; in contrast, sensing the antigen peptides through MHC II molecules on APCs, CD4 T cells 
differentiate into several subtypes of effector T helper (Th) cells, including the best-studied ones, Th1, 
Th2, Th17, and regulatory T (Treg) cells (Murphy et al., 2008). Th1 cells, secreting interferon (IFN)-γ, 
tumor necrosis factor (TNF)-α, and granulocyte/macrophage colony-stimulating factor (GM-CSF), 
attack intracellular foreign antigens carried by the macrophages and help B cells to differentiate into 
plasma cells that mainly produce immunoglobulin (Ig) G; Th2 cells, releasing IL-4, IL-5, and IL-13, 
primarily mediate plasma cells to produce IgE and secretory IgA (sIgA); Th17 cells produce IL-17, 
which preserves the integrity of the mucosal barrier and combats pathogens; Treg cells, producing 
cytokines such as IL-10 and transforming growth factor-β, establish immune tolerance to self-antigens 
and inhibit redundant immune responses (Murphy et al., 2008; Sakaguchi et al., 2008; Gensollen et al., 
2016).  
After encountering the antigens, naïve B cell are activated with or without the assistance of Th cells. 
When activated in a T cell-independent way, the humoral immune response is less robust. For example, 
bacterial polysaccharides attach to B-cell receptors and thus induce the development of plasma cells, 
but fail to generate memory B cells in most cases (Pollard et al., 2009). The antigens (invaded bacteria, 
viruses, and their products) bound to antibodies produced by plasma cells are detected and eliminated 
by phagocytes or through complement activation (Murphy et al., 2008). 
Effector T cells and primed B cells in MLNs enter the bloodstream, but exhibit gut-homing capacities, 
i.e. they return to the LP through the circulation (Brandtzaeg and Johansen, 2005). In the LP, dimeric 
sIgA antibodies produced by plasma cells are attached to the polymeric immunoglobulin receptors 
(pIgRs) on the basolateral side of IECs and transported across the epithelium to the lumen, where they 
bind to foreign antigens and limit the penetration of luminal bacteria, thus fortifying the epithelial 
barrier (Hooper and Gordon, 2001; Macpherson and Harris, 2004; Perez-Lopez et al., 2016). 
Tolerance 
The intestinal immune system develops tolerance to harmless antigens, such as diet and host gut 
microbiota (Mowat, 2003). Defect in immune tolerance to the gut microbiota is considered as an 
important cause of inflammatory bowel disease (IBD) (Round and Mazmanian, 2010). The underlying 
mechanisms for the immune tolerance are associated with innate and adaptive immunity.  
In the presence of the gut microbiota and under normal healthy conditions, DCs, via surface receptors, 
can capture some of the invading gut-resident bacteria through M cells or directly access the intestinal 
lumen via the protruding dendrites (Macpherson and Uhr, 2004; Kelsall, 2008). Subsequently, they 
migrate to and are confined in the MLNs, which primes the local mucosal immune responses but avoids 
systemic immunity (Macpherson and Uhr, 2004). 
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The location of PRRs on IECs is of great importance in gut homeostasis (Artis, 2008). Certain TLRs 
(TLR3, TLR7, and TLR8) and nucleotide-binding oligomerization domain-like receptors are 
respectively found in the endosome and cytoplasm of IECs (Peterson and Artis, 2014), which keeps 
them at a distance from the gut microbiota residing in the lumen and mucus layer, largely limiting direct 
contact with these microbes and thus preventing the activation of immune responses by IECs. The 
locations of TLRs on IECs are illustrated in Figure 2. Moreover, TLR5 is considered to be located on 
the basolateral side of IECs. It detects basolaterally translocated flagellins in IECs, thus activating 
proinflammatory immune responses (Gewirtz et al., 2001a). As an example, the enteropathogen 
Salmonella typhimurium (but not intestinal E. coli) has the potential to transfer flagellins to the 
basolateral side without bacterial invasion (Gewirtz et al., 2001a). Furthermore, after encountering the 
microbial DNA, basolateral TLR9 triggers NF-κB signaling; in contrast, recognition of microbial 
ligands by apical TLR9 not only inhibits NF-κB pathway, but also induces tolerance that inhibits 
inflammatory signaling (e.g., NF-κB activation and IL-8 production) activated by the subsequent 
stimulation of other TLRs (Lee et al., 2006).  
 
Figure 2. Toll-like receptors of intestinal epithelial cells and their bacterial ligands. IκB, inhibitor 
of NF-κB; IKKs, kinases of IκB; PG, peptidoglycan; LTA, lipoteichoic acid; LPS, lipopolysaccharide; 
MyD88 and TRIF, signaling adaptor proteins; CpG, a cytosine nucleotide linked to a guanine nucleotide 
by a phosphate. Adapted from Peterson and Artis, 2014; and Kawai and Akira, 2010.  
The presentation of gut microbe-derived antigens by retinoic-acid-receptor-related orphan receptor-γt 
positive (RORγt+) innate lymphoid cells through MHC II limits the T-cell response primed by the gut 
microbes and can also directly cause the death of these activated T cells, thereby contributing to the 
maintenance of immune tolerance towards the microbiota (Hepworth et al., 2013; Hepworth et al., 2015). 
Furthermore, gut sIgA antibodies can mediate tolerance to gut microbes. Secreted IgA adheres to the 
surface of the bacterial antigens to avert gut-associated bacteria–host interaction, which would 
otherwise lead to unnecessary immune responses (Honda and Littman, 2016). For instance, the gut 
symbiont bacterium Bacteroides thetaiotaomicron induces robust pro-inflammatory responses in 
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germfree mice lacking secreted IgA (Peterson et al., 2007). Moreover, intestinal Treg cells expressing 
transcription factor forkhead box P3 (Foxp3) are largely implicated in tolerance towards the gut 
microbiota (Bilate and Lafaille, 2012; Cebula et al., 2013). Intracellular Foxp3 mediates the 
development and function (e.g. suppression of immune response) of Treg (Fontenot et al., 2003). 
Tolerogenic Foxp3+ Treg cells are more abundant in the intestinal LP than in other parts of body 
(Atarashi et al., 2011). It has been reported that the gut microbiota can induce the development of 
Foxp3+ Treg cells (Round and Mazmanian, 2010; Atarashi et al., 2011) and shape the diverse TCR 
repertoire on them, which is distinct from that on other intestinal T-cell subsets (Lathrop et al., 2011). 
Recognition of antigens derived from the gut microbiota by TCRs on Foxp3+ Treg and other types of 
Treg cells can lead to the secretion of anti-inflammatory cytokines (e.g. IL-10 and transforming growth 
factor-β), which also contributes to immune tolerance (Sakaguchi et al., 2008).  
2.1.2 Intestinal epithelial barrier 
In addition to the immunological defense systems, the cell composition and structure of the epithelial 
layer are of paramount importance for gut functions and homeostasis. The intestinal epithelium is made 
up of a single layer of epithelial cells of several types. Enterocytes, the major class of IECs, are in 
charge of absorption, while specialized and secretory IECs promote digestive or barrier functions 
(Peterson and Artis, 2014). Specifically, enteroendocrine cells secret a variety of hormones that assist 
in digestion. Goblet cells synthesize trefoil peptides and mucins (e.g., MUC1 and MUC2) that form a 
mucus layer located directly above the epithelial layer (Figure 1), thereby protecting the gut by reducing 
the contact between IECs and the gut microbiota. For instance, mucin MUC2-lacking mice 
spontaneously suffer from colonic inflammation (Van der Sluis et al., 2006). Paneth cells, another type 
of specialized IECs, are capable of secreting many antimicrobial peptides (e.g., defensins), which break 
down important bacterial surface components (e.g., surface membranes and Gram-positive cell wall 
peptidoglycans) in order to minimize the bacterial number at the intestinal epithelial surface 
(Tlaskalová-Hogenová et al., 2011; Peterson and Artis, 2014). The adjacent epithelial cells are 
connected by junctions, including tight junctions (TJs), adherens junctions, and desmosomes (Figure 
1), thus forming a well-sealed epithelium (Turner, 2009). Among them, the TJ is the most decisive 
factor in controlling mucosal permeability. It is mainly composed of various proteins, including 
transmembrane (e.g., claudin family and occludin) and peripheral membrane proteins (e.g. zonula 
occludens, ZO) (Turner, 2009). Collectively, these structural characteristics lead to intact barriers that 
prevent the invasion of gut-resident microbes and pathogens, and, together with the immunological 
defense systems and the normal gut microbiota (see below), lay the foundation for maintaining intestinal 
immune homeostasis.  
2.2 Gut microbiota 
The microbiota residing in the mammalian gut lumen and mucosa represents greater diversity and larger 
number of microbes (bacteria, viruses, and parasites) than the microbiota in other niches of the body. 
Human gut microbiota contains about 100 trillion organisms, which is approximately equal to the total 
number of human cells in the body (Sender et al., 2016). Collectively, 99.1% of the human gut 
microbiome (collective genome of the gut microbiota) is of bacterial origin (Qin et al., 2010), and it is 
estimated that 100–1000 bacterial species reside in the human gut (Browne et al., 2016). Along the GIT, 
the concentration of oxygen continuously declines, while the diversity and abundance of intestinal 
bacteria gradually rise in both the human and animal gut, as illustrated in Figure 3. For instance, the 
upper bowel in humans, from the stomach to the jejunum, possesses fewer bacteria, ranging from 101 
to 107 organisms per ml of intestinal content, while the distal small intestinal tract and colon harbor 1010 
to 1013 per ml (Dethlefsen et al., 2006; O'Hara and Shanahan, 2006; Sekirov et al., 2010; Zoetendal et 
al., 2012). Most gut bacteria are considered uncultivable in laboratories (Walker et al., 2014). However, 
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a recent study challenged such a notion, demonstrating that a large proportion of human gut bacteria 
are cultivable by using a novel workflow that combines metagenomics and culture (Browne et al., 2016). 
With more cultivable bacteria, it is possible to characterize the gut microbiota at the species level, 
further expanding our knowledge of this “newly considered organ”. 
As previously mentioned, the gut microbiota consists of autochthonous (indigenous) microbes that 
persistently colonize the GIT and allochthonous (transient) members that pass through the GIT like 
hitchhikers (Ley et al., 2006a). Autochthonous microbes are thought to be in close contact with the 
mucosa, while allochthonous microbes mainly reside in the intestinal lumen (Nava and Stappenbeck, 
2011). In general, both autochthonous and allochthonous gut microbes may represent different types of 
symbiotic relationships with the host, including mutualism, commensalism, or parasitism (Walter et al., 
2011). In particular, mutual benefit between the host and the microbes is considered to be the main 
status (Macpherson and Harris, 2004). The GIT provides a nutrient-rich niche for the gut microbiota 
with steady growth conditions under most circumstances, while in return the gut microbiota assists the 
GIT in fulfilling its functions.  
There has been increasing interest in studying the structure and composition of the gut microbiota, 
especially that of humans. Fecal samples, which resemble the bacterial composition of the distal colon, 
have frequently been used in most of the studies, but lumen contents and mucosal samples from different 
segments of the GIT have also been investigated. Generally, the gut microbiota is divided into the 
mucosal and luminal one, and these two microbiotas differ in microbial populations and functions 
(Eckburg et al., 2005). For example, in humans, the anaerobe/aerobe ratio in the luminal microbiota is 
higher than that in the mucosal microbiota (O'Hara and Shanahan, 2006). Since the mucosal microbiota 
is closer to the intestinal epithelium, it might be more important in mediating mucosal immune 
responses, while the luminal microbiota might be more involved in digestion (Van den Abbeele et al., 
2011).  
2.2.1 Structure and composition of the gut microbiota of humans and pigs 
Humans and pigs share many similarities in the anatomy and physiology of the GIT, which is made up 
of the stomach, small intestine (duodenum, jejunum, and ileum) and large intestine (cecum, colon, and 
rectum), as shown in Figure 3 (Pond and Houpt, 1978; Pryde et al., 1999; Loh et al., 2006). Nevertheless, 
the lengths of the small intestine and colon of adult pigs are about 15–22 m and 4–6 m, respectively 
(Mochizuki and Makita, 1998), while the corresponding values are approximately 6 m and 1.5 m in 
adult humans. With regard to physiological functions, the stomach mainly initiates the breakdown of 
proteins and fats. It produces hydrochloric acid, which makes the stomach acidic and also assists in the 
conversion of saliva-sourced nitrite to nitric oxide, eliminating swallowed pathogens (Benjamin et al., 
1994). The small intestine, with bile acids secreted in the duodenum and digestive enzymes present 
along the whole length, is primarily in charge of the digestion and absorption of ingested food, including 
carbohydrates, proteins and fat, as well as the absorption of most vitamins, iron, calcium, and water 
(Ganong and Ganong, 1995). The large intestine is responsible for final water absorption and the 
digestion of indigestible substances through microbial fermentation (Ganong and Ganong, 1995; 
Bäckhed et al., 2005).  
Human gut microbiota 
The advent of modern technologies, such as 16S ribosomal RNA gene-based sequencing, metagenomics, 
and transcriptomics, has enabled the detection of a much wider range of bacterial identities at the species 
level and facilitated the study of the impact of human gut microbiota on host health. Irrespective of 
differences in age and geographic location, it has been reported that the human gut microbiota is 
dominated by four phyla: Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria (De Filippo et 
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al., 2010; Li et al., 2014; Odamaki et al., 2016). However, accumulated evidence has shown that the 
composition of the gut microbiota changes from birth to later life. 
The delivery mode, feeding methods, and antibiotics greatly affect the gut microbiota composition in 
infants (Penders et al., 2006; Dominguez-Bello et al., 2010). Generally, the infant gut microbiota has 
smaller bacterial loads (Mariat et al., 2009) and larger variation between individuals (Yatsunenko et al., 
2012) in comparison to the microbiota of older age groups; in babies fed with either breast milk or 
formula, it is dominated by the genus Bifidobacterium. With the introduction of solid foods, the bacterial 
diversity increases and the composition is modified: bifidobacteria and members of the 
Enterobacteriaceae family decrease, while Lachnospiraceae and Ruminococcaceae increase (Fallani et 
al., 2010; Bergström et al., 2014). An adult-like gut microbiota is developed within the first three years 
(Yatsunenko et al., 2012; Bergström et al., 2014). Based on the analysis of fecal samples or colonic 
mucosal tissue from healthy adults, the gut microbiota in healthy human adults mainly consists of the 
two most abundant phyla, Firmicutes and Bacteroidetes (Eckburg et al., 2005; Qin et al., 2010), in which 
most of the members are anaerobic, and which include the genera Eubacterium, Clostridium, 
Ruminococcus, Faecalibacterium, and Bacteroides (Palmer et al., 2007). Studies on the bacterial 
composition of the small intestine in healthy adults are considerably limited compared to those of the 
colon. In general, the small intestine has a lower bacterial diversity than the colon, as revealed by 16S 
rRNA gene sequencing and metagenomics (Booijink et al., 2010; Zoetendal et al., 2012). Ileostomy 
effluent samples from one healthy adult revealed that the small intestine was dominated by Clostridium, 
Streptococcus, E. coli, and high G+C Gram-positive bacteria (Zoetendal et al., 2012). Subsequently, 
another study found that ileostomy samples from four healthy adults were dominated by the genera 
Streptococcus and Veillonella (den Bogert et al., 2013). The gut microbiota in elderly people also shows 
changes compared to younger adults. Typically, Bacteroidetes is more abundant and the most dominant, 
while members of Firmicutes are decreased (Claesson et al., 2011). A higher abundance of Bacteroides, 
Eubacterium, and Clostridiaceae has also been observed in elderly Japanese over 70 years old 
(Odamaki et al., 2016). In addition to age, many other factors are also associated with the individual 
variability in bacterial composition, such as diet and antibiotics. However, the gut microbiota within an 
individual is relatively stable upon perturbations throughout life (Lozupone et al., 2012).  
Pig gut microbiota 
The bacterial composition of the pig gut microbiota resembles that in humans. Firmicutes and 
Bacteroidetes are also predominant in pigs at any age (Lamendella et al., 2011; Looft et al., 2012; Kim 
and Isaacson, 2015); however, differences between these two mammals still exist (Figure 3). For 
instance, bifidobacteria either cannot be found or are detected at low levels in the pig gut (Leser et al., 
2002; Dowd et al., 2008; Petri et al., 2010; Zhao et al., 2015), whereas they are common colonizers in 
the human gut (Turroni et al., 2008). In contrast, the genus Lactobacillus is abundant in the pig gut 
microbiota (Dowd et al., 2008; Niu et al., 2015), while lactobacilli are subdominant in the human gut, 
comprising maximally about 1% of the total bacteria (Guarner and Malagelada, 2003; Mueller et al., 
2006). In studies that have used strict anaerobic culture methods, the majority of pig gut bacteria have 
been identified as Gram positive and have mainly included lactic acid bacteria (LAB, mostly consisting 
lactobacilli and streptococci), eubacteria, and clostridia (Salanitro et al., 1977; Russell, 1979; Robinson 
et al., 1984; Pryde et al., 1999). Subsequently, comparative 16S DNA sequencing analysis has not only 
confirmed the above findings, but also revealed that the genera Bacteroides and Prevotella dominate in 
the less-abundant Gram-negative group (Leser et al., 2002). In the GIT of newborn and suckling piglets, 
the first dominant colonizers include clostridia and lactobacilli (Konstantinov et al., 2006; Petri et al., 
2010). From weaning to maturity, these bacteria are still predominant, even though the relative 
proportions show fluctuations (Konstantinov et al., 2006). Similarly to the human gut microbiota, the 
bacterial number in the lumen content of pigs is much higher than that of the intestinal wall, based on 
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direct microscopic counts and viable colony counts (Allison et al., 1979; Russell, 1979; Pryde et al., 
1999). Recently, a broader view of the ecology of the pig gut microbiota in different regions of the GIT 
was presented. It was found by pyrosequencing that the ileum with digesta from weaned pigs (about 21 
days old) mainly contains Clostridium spp., Lactobacillus spp., Streptococcus spp., and Sarcina spp. 
(Dowd et al., 2008). Later, Isaacson and Kim (2012) revealed the bacterial composition in the jejunum, 
which was dominated by the phylum Firmicutes (90%). In contrast, Zhao et al. demonstrated that the 
main phyla in the jejunum of adult pigs include Proteobacteria (79.5%), Firmicutes (18.7%), and 
Bacteroidetes (1%) (Zhao et al., 2015). Numerous studies have shown that in the ileum, Firmicutes and 
Proteobacteria are the major phyla (Dowd et al., 2008; Isaacson and Kim, 2012; Looft et al., 2014; Zhao 
et al., 2015), with Streptococcus, Clostridium, Anaerobacter, and Lactobacillus being the most 
important at the genus level. Two studies demonstrated that the major phyla in the cecum and 
colon/mid-colon were Firmicutes and Bacteroidetes (Isaacson and Kim, 2012; Looft et al., 2014), 
whereas in another study, Firmicutes and Proteobacteria were the dominant phyla (Zhao et al., 2015). 
Considering the differences in pig breeds, diet, growth conditions, and other factors, such a discrepancy 
is conceivable.   
 
Figure 3. The gastrointestinal tract and the dominant phyla or genera in different regions of the 
GIT in adult humans and pigs. Data of human studies from Dethlefsen et al., 2006; O’Hara and 
Shanahan, 2006; Sekirov et al., 2010; and Zoetendal et al., 2012. Data of pig studies from Allison et al., 
1979; Pryde et al., 1999; Konstantinov et al., 2006; Loh et al., 2006; Looft et al., 2014; and Zhao et al., 
2015. 
2.2.2 Role of the gut microbiota  
The gut microbiota has highly evolved to adapt to the host. Therefore, in healthy individuals, the 
intestinal immune system exhibits tolerance to the resident microbes, while it protects the host from 
intestinal pathogen infection. It is now evident that the interactions between the intestinal immune 
system and the gut microbiota play a vital role in the maintenance of gut homeostasis. Meanwhile, the 
gut microbiota has a role in the modulation of host metabolism and the control of invading pathogens. 
However, it is also implicated in host diseases.  
2.2.2.1 Structural and developmental effects of the intestine  
Structural development of the GIT 
In the absence of the gut microbiota, germfree mice generally have a smaller intestinal surface area 
(Gordon and Bruckner-Kardoss, 1961), longer and thinner villi, and a lower vessel density in the villi 
(Sommer and Bäckhed, 2013). However, introducing the normal gut microbiota to germfree mice 
resulted in the villi becoming shorter and wider, and thus more capable of efficiently inhibiting 
microbial invasion (Sommer and Bäckhed, 2013). Additionally, the structural development of the 
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intestinal immune system in germfree mice shows multiple defects, thus highlighting the important role 
of the gut microbiota in its development. As an example, without gut microbiota, ILFs are few and 
undeveloped, resulting in a lack of B cells (Bouskra et al., 2008; Hooper et al., 2012). However, the 
number of ILFs was increased by the colonization of germfree mice with Gram-negative gut bacteria 
(e.g., Bacteroides distasonis and E. coli) or the introduction of peptidoglycan isolated from E. coli 
(Bouskra et al., 2008). Moreover, as compared with colonized animals, germfree animals possess fewer 
and smaller PPs and MLNs, a thinner LP, and fewer plasma cells in germinal centers (Round and 
Mazmanian, 2009). Collectively, the lack of the gut microbiota results in the impaired development of 
GALTs, therefore leading to deficiencies in immune responses, as demonstrated by the observation that 
germfree mice exhibit an increased susceptibility to infections caused by enteropathogens (Round and 
Mazmanian, 2009).   
Enhancement of the intestinal epithelial barrier  
Mounting evidence has shown that the gut microbiota is capable of fortifying the physical and chemical 
intestinal barriers: the mucus layer, the epithelial layer, and secreted antimicrobial peptides (e.g. α-
defensins). In antibiotic-treated mice, the expression of MUC2 mucin, which is the major component 
of the mucus layer, was reduced in goblet cells, resulting in a thinner inner mucus layer, which in turn 
caused more severe enteric pathogen Citrobacter rodentium-derived colitis, compared to untreated mice 
(Wlodarska et al., 2011). Additionally, in germfree mice, the colonization of Bacteroides 
thetaiotaomicron (a member of the gut microbiota) strengthened the intestinal barrier functions through 
the upregulation of expression of Sprr2a protein, which contributed to the formation of desmosomes 
(Hooper et al., 2001). Moreover, gut commensal E. coli strains (e.g., E. coli Nissle 1917 and ECOR63) 
and their extracellular products enhanced the epithelial barrier function via the upregulation of ZO-1 
and claudin-14, and the downregulation of claudin-2 involved in epithelial pore formation, thus 
fortifying TJs (Ukena et al., 2007; Alvarez et al., 2016). In addition to the presence of bacterial cells, 
bacterial metabolites also fortify the epithelial barrier. As an example, short-chain fatty acids (SCFAs) 
produced by gut-resident bacteria increase MUC2 expression in IECs and modulate the location of ZO-
1 and occludin, which thus increases the trans-epithelial electrical resistance (TEER, a parameter to 
assess the epithelial barrier integrity) (Willemsen et al., 2003; Peng et al., 2009). Importantly, the gut 
microbiota has been shown to protect the intestinal epithelia from radiation-induced injury (Rakoff-
Nahoum et al., 2004) and to stimulate epithelial proliferation in the mouse small intestine (Hörmann et 
al., 2014). Additionally, the gut microbiota enhances the barrier function by inducing the production of 
antimicrobial molecules (Kamada et al., 2013). The introduction of gut-resident bacteria to germfree 
mice strongly triggers the coordinated expression of antimicrobial lectin REGIIIγ in Paneth cells, which 
binds to the peptidoglycan of luminal bacteria and thus restricts bacterial invasion (Cash et al., 2006). 
2.2.2.2 Immunological effects  
The mucus layer minimizes direct contact with the gut microbiota, and the intestinal epithelium reduces 
the interactions between the gut microbiota and the intestinal immune system. However, some bacteria 
in the gut lumen, as well as bacterial products and structural components, have the potential to 
translocate through mucus and attach to or enter the IECs, thus activating inflammatory innate immune 
responses. In a healthy host, the intestinal immune system is tolerant to the gut microbiota, but initiates 
inflammatory immune responses in order to eliminate invading pathogens. The gut microbiota has the 
potential to modulate mucosal immunity by contributing to both immunological defense and tolerance. 
Indeed, mono-colonization of germfree mice with 53 individual bacterial species from the human gut 
microbiota covering 5 dominant phyla (Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, and 
Fusobacteria) revealed that the majority of the tested bacteria had strain-specific immunomodulatory 
properties (Geva-Zatorsky et al., 2017).  
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Effects on innate immunity. Recognition of the gut-resident microbes by TLRs at the mucosal site 
is crucial for maintaining gut immune homeostasis. It has been demonstrated that antibiotic-treated mice 
lose the ability to produce cytokines via the MyD88-dependent pathway, whereas conventional mice 
yield a pronounced level of IL-6 that could protect the host from colonic injury caused by dextran sulfate 
sodium (Rakoff-Nahoum et al., 2004). Similarly, a recent study proved that, under steady-state 
conditions, sensing of microbial signaling from the gut microbiota by intestinal macrophages can 
activate the MyD88-dependent pathway and evoke IL-1β secretion, leading to the constant production 
of growth factor GM-CSF (also termed CSF2), which promotes intestinal homeostasis by regulating 
the number and function of macrophages and DCs (Mortha et al., 2014). In contrast, encountering of 
antibiotic-treated microbiota by macrophages resulted in the dysfunction of DCs (Mortha et al., 2014).  
Moreover, the gut microbiota enhances ROS generation and thus mediates innate immune responses. 
IECs contacted by gut commensal bacteria immediately produce ROS, which results in IκB degradation 
(but not dissociation from NF-κB) through cullin-dependent signaling, thus leading to the suppression 
of the NF-κB signaling pathway (Kumar et al., 2007). SCFAs produced by gut bacteria also stimulate 
ROS production. Butyrate produced by commensal bacteria degraded IκB, resulting in the inhibition of 
NF-κB activation (Kumar et al., 2009). Notably, SCFAs are also able to regulate the expression of 
cytokines and chemokines in various leukocytes and then exhibit anti-inflammatory effects (Vinolo et 
al., 2011b). For example, butyrate impairs the production of pro-inflammatory cytokines (IL-12 and 
TNF-α), but upregulates anti-inflammatory IL-10 secretion, and is also able to inhibit NF-κB activation 
(Segain et al., 2000; Säemann et al., 2000; Vinolo et al., 2011a). A recent study has demonstrated that 
other metabolites, including palmitoleic acid and tryptophan, have an inhibitory effect on the production 
of pro-inflammatory cytokines induced by certain pathogens ex vivo (Schirmer et al., 2016), suggesting 
that these metabolites may be used to treat diseases caused by excessive pro-inflammatory cytokine 
production, such as autoimmune disease.   
Effects on adaptive immunity. The gut microbiota is associated with T-cell differentiation and 
pro/anti-inflammatory cytokine production. Th17 cells are deficient in the small intestinal LP of 
germfree mice; however, upon colonization with a normal mouse gut microbiota or segmented 
filamentous bacteria (most closely related to Clostridia), they are upregulated, which promotes the 
secretion of various cytokines protecting the host from pathogen infections (Ivanov et al., 2009; 
Atarashi et al., 2015). In mice with Citrobacter rodentium infection, SCFAs promote the differentiation 
of naïve T cell into Th1 or Th17 in order to fight pathogens (Park et al., 2015). 
Meanwhile, the gut microbiota is also able to modulate Treg differentiation. Oral inoculation of a 
mixture of 17 clostridial strains isolated from human feces largely enriched Tregs and IL-10 in the colon 
LP of germfree mice, and provided protection against colitis (Atarashi et al., 2013). The three dominant 
SCFAs, butyrate, propionate, and acetate (Macfarlane and Macfarlane, 2003), also promote the 
generation of colonic Tregs and further dramatically increase the expression of Foxp3 and IL-10, which 
suppresses the excessive immune responses and protects the host against colitis (Arpaia et al., 2013; 
Furusawa et al., 2013; Smith et al., 2013).  
Furthermore, the gut microbiota plays an essential role in sIgA production. Plasma cells in the intestine 
of germfree animals are drastically decreased (Honda and Littman, 2016), and the produced sIgA fails 
to bind the bacterial components (Macpherson et al., 2000), while the introduction of a normal gut 
microbiota immediately promotes sIgA secretion. It has also been reported that sIgA diversity is 
enhanced by the increased complexity of the gut microbiota, as germfree mice colonized with the 
complex gut microbiota from specific-pathogen-free mice generate more diverse IgA repertoires than 
those colonized with single strains of gut microbes (e.g., segmented filamentous bacteria or Clostridium 
strains) (Lindner et al., 2015), therefore binding to a larger extent of antigens.  
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2.2.2.3 Protective effects against gastrointestinal pathogens 
The gut microbiota located in the mucus layer and close to the intestinal epithelia potentially acts as a 
microbial barrier to protect the host from pathogen infection, highlighted by the observation that the 
susceptibility to intestinal pathogens is largely increased in germfree and antibiotic treated-mice 
(Lawley et al., 2009; Fukuda et al., 2011). Protective effects against pathogens conferred by the gut 
microbiota are generally grouped into two types, direct and indirect inhibition, which are both based on 
multiple mechanisms (Buffie and Pamer, 2013).  
Direct inhibition of pathogens 
First of all, the ability of the gut microbiota to outcompete pathogens for common and essential nutrients 
might lead to the starvation or exclusion of pathogens (Kamada et al., 2012; Kamada et al., 2013). As 
an example, a commensal microbe, Escherichia coli Nissle 1917, outcompeted Salmonella 
typhimurium for iron and thus reduced Salmonella colonization of the GIT of chronically and acutely 
infected mice (Deriu et al., 2013). In addition, the gut microbes may inhibit pathogen colonization by 
occupying common binding sites. For instance, the adhesive L. crispatus JCM 8779 isolated from 
human feces strongly reduced the adherence of Enterococcus faecalis TT1 to Caco-2 cells (Todoriki et 
al., 2001). Furthermore, acidic conditions (e.g. lactic acid) and certain metabolites, such as SCFAs and 
antimicrobial molecules produced by the gut microbiota, have a pivotal role in pathogen inhibition. The 
growth of Escherichia coli O157:H7 is markedly inhibited by acetate, butyrate, and propionate 
produced by gut anaerobes (Shin et al., 2002; Fukuda et al., 2011). Butyrate also reduces the invasion 
of IECs by Salmonella enterica by down-regulating the expression of several virulence genes (Gantois 
et al., 2006). Bacteriocins are antimicrobial peptides secreted by various gut-resident bacteria that can 
inhibit bacterial growth. For instance, bacteriocins produced by Bacillus thuringiensis effectively kill 
clinical Clostridium difficile strains ex vivo (Rea et al., 2010). Recently, 74 bacteriocin gene clusters 
were found in the human gut microbiome (Walsh et al., 2015), suggesting that the human gut microbiota 
has the potential to inhibit intestinal pathogen growth. Notably, recent studies have demonstrated that 
antimicrobial proteins with antagonistic effects against competitors and enteric pathogens are secreted 
through the type VI secretion systems (T6SSs) of gut-dwelling bacteria in a cell-to-cell contact manner 
(Russell et al., 2014; Hecht et al., 2016). T6SSs are frequently found in the genomes of many gut-
resident bacteria, especially in members of the gut-dominant phylum Bacteroidetes (Chatzidaki-Livanis 
et al., 2016). For instance, non-pathogenic and enteropathogenic Bacteroides fragilis strains are 
ubiquitous in the GIT, and a recent in vivo study revealed that non-pathogenic B. fragilis utilizes T6SSs 
to provide colonization resistance against enteropathogenic B. fragilis and to suppress enteropathogenic 
B. fragilis-induced colitis (Hecht et al., 2016).  
Indirect inhibition of pathogens 
The gut microbiota can also indirectly inhibit pathogen colonization based on its ability to strengthen 
the epithelial barrier function and to evoke mucosal immune responses. The underlying mechanisms 
include the promotion of antimicrobial peptide expression and sIgA production, effects on T-cell 
differentiation, and pro/anti-inflammatory cytokine secretion in the host, as discussed in sections 2.2.2.1 
and 2.2.2.2. Furthermore, another indirect inhibition mechanism of pathogens is associated with the 
production of secondary bile acids, which are transformed from bile acids by the gut microbiota 
(Rolhion and Chassaing, 2016). Secondary bile acids have antimicrobial effects, as demonstrated by the 
observation that their production was decreased in antibiotic-treated mice, resulting in the colonization 
of pathogenic Clostridium difficile (Theriot and Young, 2015; Theriot et al., 2016). In another example, 
Clostridium scindens, a member of the gut microbiota that participates in secondary bile acid synthesis, 
inhibits Clostridium difficile growth in a manner dependent on secondary bile acids (Buffie et al., 2015). 
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2.2.2.4 Nutritional effects  
In accordance with the variation in bacterial composition between the small intestinal and colon 
microbiota, it has been reported that the bacteria in the small intestine are capable of the rapid uptake 
and degradation of simple carbohydrates, while colon bacteria specifically ferment complex 
carbohydrates (Zoetendal et al., 2012). The gut microbiota also enhances nutrient absorption, as 
demonstrated by the observation that the mRNA levels of genes involved in lipid absorption are elevated 
after introducing a gut-resident bacterial species, Bacteroides thetaiotaomicron, to germfree mice 
(Hooper et al., 2001). 
In the colon, the gut microbiota ferments indigestible carbohydrates, such as starch and fiber, and many 
of the resulting metabolites, such as SCFAs, serve as energy sources for the host (Macfarlane and 
Macfarlane, 2003; Qin et al., 2010). Specifically, as the main SCFA, most acetate is absorbed by liver 
cells and used as the substrate for cholesterogenesis and lipogenesis (den Besten et al., 2013; Canfora 
et al., 2015); propionate appears to be the precursor of gluconeogenesis, while butyrate is a substrate 
for lipogenesis (Wong et al., 2006; Canfora et al., 2015) and the preferred energy source for colon 
epithelial cells (Donohoe et al., 2011). Additionally, SCFAs have other nutritional functions in the body, 
as they may, for instance, promote adipocyte differentiation, insulin sensitization, and blood glucose 
level control (Canfora et al., 2015). Collectively, the potential of bacterial metabolites to modulate the 
host metabolism may affect the ability of the host to maintain blood glucose levels and lipid content, as 
well as body energy homeostasis. An imbalanced gut microbiota produces imbalanced metabolites that 
may lead to host diseases. The gut microbiota is also involved in drug detoxification (Claus et al., 2011) 
and the beneficial transformation of bioactive compounds (O'keefe, 2016), whereas it is additionally 
implicated in some detrimental activities as well, such as the generation of carcinogens (Hope et al., 
2005) and the activation of genotoxicants (Blaut et al., 2006).  
In addition to SCFAs, certain gut bacteria are suppliers of amino acids and vitamins, including vitamins 
of the B group (e.g., folate and riboflavin) and vitamin K (Hill, 1997; Qin et al., 2010). Vitamin 
production by the gut microbiota compensates for the biosynthesis deficiency of many essential 
vitamins in humans (Hill, 1997; LeBlanc et al., 2013). Compared to conventionally reared animals, 
germfree animals require vitamin K and more B-group vitamins in their diet (Sumi et al., 1977; 
Wostmann, 1981), indirectly suggesting that bacterially synthesized vitamins can be assimilated by the 
host. A study performed in humans directly demonstrated that folate produced by small intestinal 
bacteria was absorbed and used by the human body (Camilo et al., 1996).   
2.2.2.5 Pathogenic effects  
An increasing number of studies have demonstrated that the gut microbiota is associated with various 
disorders of metabolism, the GIT, heart and brain. These disorders include type 1 (Vatanen et al., 2016) 
and 2 diabetes (Mardinoglu et al., 2016), obesity (Ley et al., 2006b), liver diseases through the gut–
liver axis, alcoholic (Yan et al., 2011) and nonalcoholic fatty liver disease (Abu-Shanab and Quigley, 
2010)), irritable bowel syndrome (IBS) (Kassinen et al., 2007),  IBD (Morgan et al., 2012), heart failure 
(Kamo et al., 2017), asthma (Abrahamsson et al., 2014), allergy (West et al., 2015), GI and non-GI 
cancers (Yoshimoto et al., 2013; Louis et al., 2014), and even anxiety and depression (Foster and 
Neufeld, 2013), autism (Strati et al., 2017), multiple sclerosis (Berer et al., 2011), and Parkinson’s 
disease (Scheperjans et al., 2015) through the gut–brain axis. An imbalanced gut microbiota has been 
associated with the pathogenesis of these diseases, but whether the dysbiosis is a causative contributor 
or a consequence of these disorders remains in most cases unknown. Dysbiosis is characterized by the 
reduction in commensals and diversity, and the expansion of pathobionts, i.e. bacteria that live as 
commensals in the GIT under normal circumstances, but which have the potential to cause  diseases 
(Levy et al., 2017). For instance, a reduced abundance of Firmicutes (e.g. Faecalibacterium prausnitzii) 
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and a relative enrichment in Enterobacteriaceae (e.g. E. coli) was observed in patients suffering from 
IBD, both in Crohn’s disease affecting the whole GIT, and in ulcerative colitis only affecting the colon 
(Baumgart and Sandborn, 2007; Kostic et al., 2014; Matsuoka and Kanai, 2015). Treatments, such as 
fecal microbiota transplantation and probiotics, aiming at normalizing the gut microbiota, have been 
employed with promising outcomes to ameliorate IBD (Matsuoka and Kanai, 2015).  
2.3 Lactic acid bacteria 
LAB, also termed as the order Lactobacillales, are Gram-positive, nonsporulating cocci or rods, which 
are listed under the phylum Firmicutes (Von Wright and Axelsson, 2011). They inhabit a variety of 
niches, including the environment, plants, fermented food, skin, the oral cavity, and the GIT of 
mammals. Since ancient times, LAB have been extensively used in food processing, such as food 
fermentation. Meanwhile, they are generally considered as safe bacteria with various health-promoting 
properties. Among LAB, Lactobacillus, Lactococcus, Streptococcus, Leuconostoc, Pediococcus, and 
Enterococcus are the most important genera (Makarova et al., 2006). Based on their fermentation 
characteristics, LAB are divided into homofermentative LAB, which produce lactic acid as the main 
end-product, and heterofermentative LAB, which produce lactic acid as well as carbon dioxide, acetic 
acid, and ethanol (Kandler, 1983). In the human GIT, LAB account for a small part of the gut microbiota 
(Douillard and de Vos, 2014). For instance, in the study of Rossi et al. (2016), their abundance was 
0.08–0.3% of the total bacteria in human fecal samples. Nevertheless, they provide many beneficial 
effects to the host. Lactic acid and other metabolic products (e.g. bacteriocins) have antimicrobial 
effects that are able to inhibit infection by various pathogens (Dicks and Botes, 2009). LAB also 
synthesize important vitamins in the GIT, such as folate and riboflavin (LeBlanc et al., 2013). 
Importantly, LAB possess immunomodulatory properties that strengthen host immunity (Perdigon et 
al., 2002; Dicks and Botes, 2009).  
2.3.1 The genus Lactobacillus 
Lactobacillus is the largest and highly heterogeneous genus of LAB (Claesson et al., 2007), with 
currently more than 220 species identified from various origins (http://www.bacterio.net, last searched 
September 2017). Members of the genus Lactobacillus are rod-shaped, anaerobic or aerotolerant 
bacteria, classified as obligately homofermentative, or facultatively/obligately heterofermentative 
lactobacilli (Hammes and Vogel, 1995). Lactobacillus species have a long history of utilization in food 
production and preservation. Due to their beneficial effects, Lactobacillus strains have been consumed 
as probiotic supplements by humans and animals more frequently than other LAB (Ouwehand et al., 
2002). Additionally, some genetically modified lactobacilli have proven to be effective delivery vectors 
of foreign (immunogenic or therapeutic) antigens in mucosal vaccination (Wyszyńska et al., 2015). 
Furthermore, a recent study has revealed that the clustered regularly interspaced short palindromic 
repeats (CRISPR)-Cas adaptive immune systems are broadly present in lactobacilli (Sun et al., 2015). 
CRISPR-Cas systems contribute to resistance to foreign genetic material, such as bacteriophage DNA 
(Horvath and Barrangou, 2010), consequently increasing the survival rates of lactobacilli in competitive 
environments, such as the GIT. 
In the GIT, lactobacilli are either permanent colonizers or transient passengers. Thus far, it has been 
demonstrated that in the Lactobacillus genus, L. ruminis, L. salivarius, L. gasseri, and L. reuteri are 
truly autochthonous species (Tannock et al., 2000; Reuter, 2001), which have adapted to the host GIT 
environment and are thus able to colonize certain sites lifelong. In contrast, several well-studied species, 
including L. acidophilus and one of the best characterized health-promoting microbes, L. rhamnosus 
GG, originate from food products and have been referred to as allochthonous strains (Walter, 2008).  
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2.3.1.1 Probiotic lactobacilli 
As defined by the World Health Organization (WHO), probiotics are live microorganisms that confer a 
health benefit on the host when administered in adequate amounts. Possible probiotic actions are 
illustrated in Figure 4. Probiotics are versatile with regard to their functions. They have been proposed, 
for example, to cure or prevent diarrhea (Isolauri et al., 1991; Szajewska and Mrukowicz, 2001; 
Dendukuri et al., 2005), control IBS and IBD (Kruis et al., 1997; Niedzielin et al., 2001; Whelan and 
Quigley, 2013), prevent necrotizing enterocolitis in babies (Lin et al., 2005; AlFaleh and Anabrees, 
2014) and atopic dermatitis in infants and young children (Kalliomäki et al., 2001; Kalliomäki et al., 
2003; Pelucchi et al., 2012), reduce cholesterol levels (Ooi and Liong, 2010), ameliorate constipation 
(Chmielewska and Szajewska, 2010), and relieve allergies and asthma (Majamaa and Isolauri, 1997; 
West et al., 2016).  
Therefore, searching for probiotic candidates is still of great interest nowadays. The screening process 
is based on a few established selection criteria. First and foremost, probiotics must be safe to the host. 
Another important prerequisite is that, in order to maintain the viability of the bacteria, candidate 
probiotics should be able to withstand the harsh conditions encountered during industrial processing as 
well as in the GIT (e.g. the acidity in the stomach). Furthermore, an adhesive property is a priority for 
a candidate probiotic in order to increase retention in the GIT and to interact with the host. Targets used 
when testing adherence in vitro usually comprise extracellular matrix (ECM) proteins, intestinal mucus, 
intestinal epithelial cells (e.g., Caco-2 and HT-29), and host tissues (Ouwehand and Salminen, 2003). 
Additionally, based on adhesion, candidate probiotics should also have potential to inhibit the adhesion 
of gastrointestinal pathogens to host tissues, and thus provide beneficial effects (Collado et al., 2007). 
The commonly employed in vitro inhibition assay types, based on the same substrates as the adhesion 
tests, are the following: competition (probiotics and pathogens are added simultaneously), competitive 
exclusion (probiotics are added before pathogens), and displacement (pathogens are added before 
probiotics) (Lee et al., 2003; Collado et al., 2007; Hynönen et al., 2014). The following mechanisms 
have been suggested to underlie inhibition: i) competition for common adhesion sites on the host 
intestinal mucosa, ii) bacterial coaggregation, and iii) the secretion of inhibitory proteins (Lebeer et al., 
2008; Hynönen et al., 2014). Lastly, still another practical requirement is that preferably it should be 
possible to consider candidate probiotics as immune boosters that have the potential to modulate 
immune responses (Delcenserie et al., 2008). 
In addition to Lactobacillus, Bifidobacterium and other LAB strains such as Streptococcus thermophilus 
(Saavedra et al., 1994), Streptococcus salivarius K12 (Burton et al., 2006), and Enterococcus faecium 
(Hlivak et al., 2005) are commonly consumed as probiotics. Commercial probiotic products can contain 
single bacterial strains or mixtures of several species representing several genera (Table 1). Examples 
of the proposed health-promoting properties of lactobacilli currently used as probiotics in Finland are 
listed in Table 1.  
 
Figure 4. Proposed beneficial actions of Lactobacillus probiotics. Adapted from Lebeer et al., 2008. 
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Notably, in contrast to the probiotic side, there is evidence showing the pathogenic potential of lactobacilli, as 
they may sometimes cause diseases in compromised individuals. Lactobacillus sepsis has been found in 
children supplemented with L. rhamnosus GG to treat and prevent short gut syndrome (Kunz et al., 2004), 
necrotizing enterocolitis (Dani et al., 2016), or antibiotic-associated diarrhea (Land et al., 2005; Dani et al., 
2016). Furthermore, a premature infant developed sepsis that was caused by L. acidophilus infection obtained 
through an inserted intravenous central catheter (Thompson et al., 2001). Nevertheless, in total only a few 
severe infection cases caused by Lactobacillus in high-risk patients have been reported. Therefore, collectively, 
Lactobacillus are generally considered safe. 
2.3.1.2 Selected Lactobacillus surface structures 
As in other Gram-positive bacteria, the cell wall of Lactobacillus consists of a thick and multilayered 
peptidoglycan, and membrane-bound and cell wall-bound components. A schematic illustration of the surface 
structures of Lactobacillus is presented in Figure 5. Specifically, lipoproteins, lipoteichoic acids (LTA), and 
flagella are anchored to the cell membrane, while teichoic acids, pili, and S-layers, as well as other cell wall 
polysaccharides including exopolysaccharides (EPS), are either covalently or non-covalently anchored to the 
peptidoglycan (Desvaux et al., 2006; Lebeer et al., 2008; Schneewind and Missiakas, 2012). Structural 
variations in cell surface composition exist in different species/strains. Notably, certain surface components, 
such as S-layers, pili, and flagella, are strain/species-specific and only present in some lactobacilli. 
Lactobacillus surface structures have versatile functions that are associated with immunomodulatory, adhesive, 
and protective properties, as well as with motility, and they fundamentally contribute to the reported health-
promoting effects.  
 
Figure 5. Schematic presentation of the surface structures of Lactobacillus. LTA, lipoteichoic acid; EPS, 
exopolysaccharide; WTA, wall teichoic acid; PG, peptidoglycan. Pili, EPS, WTA, and the S-layer are anchored 
to the PG. Flagella, LTA, and lipoproteins are anchored to the cytoplasmic membrane. Data from Desvaux et 
al., 2006; Lebeer et al., 2008; and Schneewind and Missiakas, 2012. 
2.3.1.2.1 Pili 
Pili, also known as fimbriae, are hair-like surface appendages, protruding from the body of certain Gram-
positive and Gram-negative bacteria, and implicated in adhesion, biofilm formation, and conjugation (Christie, 
2001; Proft and Baker, 2009). In Gram-positive bacteria, pili are very thin (a few nanometers across) but long, 
being a few micrometers in length (Kang and Baker, 2012). In 1968, pili in a Gram-positive bacterium were 
first observed in Corynebacterium renale by electron microscopy (EM) (Yanagawa et al., 1968). Subsequently, 
an increasing number of piliated pathogenic and non-pathogenic Gram-positive bacteria have been detected 
by EM, such as Streptococcus (Lauer et al., 2005), Actinomyces (Mishra et al., 2007), and even probiotic 
bifidobacteria (Motherway et al., 2011). In older studies, several Lactobacillus strains were demonstrated to 
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have pili on the surface by EM, including Lactobacillus fermentum (Barrow et al., 1980) and vaginal isolates 
(L. acidophilus, L. jensenii, L. fermentum, L. rhamnosus, and L. casei) (McGroarty, 1994). Recently, pili have 
been observed on Lactobacillus johnsonii (Pridmore et al., 2004) and L. rhamnosus GG (Lebeer et al., 2009). 
However, only a few pilus gene clusters have been found in lactobacilli. One pioneering study demonstrated 
that the genome sequence of L. johnsonii NCC 533 has a fimbrial operon (Pridmore et al., 2004). Thereafter, 
a comparative genomic analysis revealed the presence of spaCBA and spaFED gene clusters in L. rhamnosus 
GG, each cluster being composed of three pilin genes and a sortase-specific gene (Kankainen et al., 2009). 
Subsequently, these two pilus gene clusters have also been identified in 36 strains of the species L. paracasei 
(Smokvina et al., 2013). Recently, a comparative genomic study revealed that 51 LAB strains in 
L.casei/rhamnosus, L. ruminis, Lactobacillus brevis/parabrevis, and Lactobacillus composti clades were 
predicted to have altogether 67 pilus gene clusters; of these 51 strains, 42 strains possessed one pilus cluster 
(Sun et al., 2015).  
Structurally, typical pilus shafts in Lactobacillus are composed of the major pilin protein (SpaA) building up 
the pilus shaft, and one or two minor pilins (SpaB and SpaC) that are located at the pilus base and tip, 
respectively. In contrast to Gram-negative bacteria, these pilins are covalently connected to each other, and the 
pilus shaft is covalently linked to the bacterial cell wall. Each pilin harbors an LPXTG sorting motif, specific 
for sortase recognition, at the carboxyl terminus (Kang and Baker, 2012). Sortases are membrane-associated 
transpeptidases and, of the several classes of sortases, those of classes A and C mediate pilus assembly 
(Hendrickx et al., 2011). Additionally, many pilins possess the YPKN pilin motif and the E box, which are 
essential for pilus assembly (Mandlik et al., 2008b).   
Until 2003, the mechanism of pilus assembly had only been uncovered in the pathogen Corynebacterium 
diphteriae (Ton-That and Schneewind, 2003), thereafter being used as a paradigm of pilus assembly in Gram-
positive bacteria. Pilins are exported across the bacterial membrane via the Sec-dependent pathway, while the 
hydrophobic domain of each pilin is anchored to the membrane (Danne and Dramsi, 2012). Typically, pilus 
polymerization takes place when the pilus-specific sortase C (also called pilin-specific sortase) cleaves the 
LPXTG motif of the tip and backbone pilins, forming an acyl-enzyme intermediate that continues to recruit 
backbone pilins, until the basal pilin connects to the pilin shaft by polymerization of sortase A, which attaches 
the pili to the cell wall (Danne and Dramsi, 2012).  
Gram-positive pili are involved in various activities. In Gram-positive bacteria, pilins not only work as 
adhesins that facilitate bacterial colonization in the host, but also contribute to biofilm development (Mandlik 
et al., 2008b). Importantly, Gram-positive pili interact with host immunity (Danne and Dramsi, 2012). 
However, to date, the characteristics of Lactobacillus pili have only been studied in L. rhamnosus GG, 
discussed in chapter 2.3.1.3.1 
2.3.1.2.2 Flagella 
Flagella, projecting out from the body of prokaryotic cells, are essential organelles that mediate motility. From 
the bacterial perspective, flagellar clockwise and anticlockwise rotation generates the tumbling and running 
(swimming or swarming) movements, respectively (Korani et al., 2009). Flagellar organization on both Gram-
positive and negative bacteria can be grouped into four patterns, including monotrichous (one polar flagellum), 
amphitrichous (two polar flagella at opposite sites), lophotrichous (a few polar flagella at one site), and 
peritrichous (many flagella around the bacterial body) (Leifson, 1951). Given the significant sequence 
conservation of genes associated with flagellar assembly, both Gram-positive and negative bacteria appear to 
generate flagella similarly (Beatson et al., 2006). The flagellar structure is composed of several parts: the basal 
body, the motor, the switch, the hook working as a universal joint, the helical filament, capping proteins, and 
junction proteins located between the hook and the filament (Macnab, 2003). The rod of the basal body, which 
is embedded in the cell wall, markedly differs between Gram-positive and negative bacteria (Altegoer et al., 
2014). Flagellin, also known as FliC, constitutes the flagellar filament (Ramos et al., 2004). There are several 
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domains in the flagellin, including the D0 and D1 domains highly conserved in all bacteria, and variable 
domains that differ not only between Gram-positive and negative bacteria, but also within Gram-positive or 
negative bacteria (Smith et al., 2003; Beatson et al., 2006; Altegoer et al., 2014). After being recognized by 
TLR5 on the host cells, flagellins of Gram-positive and negative bacteria activate either the NF-κB or the p38 
MAPK signaling pathway; the choice appears to be dependent on the TLR5 binding site of the D1 domain 
(Hayashi et al., 2001; Smith et al., 2003; Yu et al., 2003; Verma et al., 2005). 
Motility provides bacteria with tremendous benefits, as demonstrated by strains not belonging to the genus 
Lactobacillus. Motile bacteria are able to reach favorable niches for colonization and nutrient intake, and 
escape toxic substances (Ottemann and Miller, 1997). Flagella may also contribute to the pathogenicity of 
some pathogenic bacteria by propelling them to the targeted location of the host. For instance, the gastric 
pathogen Helicobacter pylori uses such motility to colonize the stomach, leading to disease, whereas 
flagellated but non-motile mutants are less able to access infection sites, being thus less virulent (Ottemann 
and Lowenthal, 2002). Additionally, flagella facilitate biofilm formation in both Gram-positive and Gram-
negative bacteria (O'Toole et al., 2000; Lemon et al., 2007; Houry et al., 2010). A biofilm is a collection of 
bacteria growing on a surface and frequently embedded in an extracellular polymeric matrix. It protects the 
bacteria against the harsh environment and harmful agents, e.g. antibiotics (Costerton et al., 1999; O'Toole et 
al., 2000). When coated by a biofilm, some pathogens, such as Pseudomonas aeruginosa, can then cause 
chronic or even life-threatening infections, such as airway infections in cystic fibrosis patients (Parsek and 
Singh, 2003). Moreover, flagella are involved in adhesion, as demonstrated by the observation that an E. coli 
mutant without flagella was less adhesive on different surfaces compared to the wild type (Friedlander et al., 
2013).  
Generally, most LAB are aflagellated. Of some strains in the genera Lactobacillus, Enterococcus (Langston et 
al., 1960), Sporolactobacillus (Kitahara and Suzuki, 1963), and Carnobacterium (Nicholson et al., 2015), 
flagella have occasionally been visualized. Flagellated lactobacilli demonstrated by EM to date are 
summarized in Table 2. Among them, most strains originate from the environment. Other motile lactobacilli 
have been reported without EM verification of flagella, including the species Lactobacillus nagelii (Neville et 
al., 2012), Lactobacillus vini (Rodas et al., 2006), Lactobacillus uvarum (Mañes-Lázaro et al., 2008), 
Lactobacillus oeni (Mañes-Lázaro et al., 2009a), and Lactobacillus aquaticus (Mañes-Lázaro et al., 2009b).  
Table 2. Flagellated Lactobacillus strains, demonstrated by electron microscopy 
Strains Origin Flagella type References 
L. ruminis  
ATCC27780 
ATCC27781 
ATCC27782 
DPC 6830 and 6831 
DPC 6832, 6833, 6834, 
6835 and 6836 
 
Bovine rumen 
Bovine rumen 
Bovine rumen 
Porcine feces 
Equine feces 
 
Peritrichous 
Monotrichous 
Peritrichous 
Peritrichous 
Peritrichous 
 
Sharpe et al., 1973  
O’Donnell et al., 2015  
Neville et al., 2012  
O’Donnell et al., 2015  
O’Donnell et al., 2015  
L. mali 
JCM 1153 JCM 1161 
JCM 3821 JCM 3822 
 
Fermented cider and wine must 
 
Peritrichous 
 
Kaneuchi et al., 1988  
L. agilis BKN88 A variant of chick strain L. agilis 
JCM 1048 
Peritrichous Kajikawa et al., 2016  
L. sucicola JCM 15457 Oak tree Peritrichous Irisawa and Okada, 2009  
L. satsumensis DSM 16230 Mashes of shochu, a Japanese 
distilled alcoholic beverage 
Peritrichous Endo and Okada, 2005  
L. ghanensis DSM 18630  Ghanaian fermenting cocoa Peritrichous Nielsen et al., 2007  
L. capillatus DSM 19910 Brine of stinky tofu, a Chinese 
traditional snack  
Peritrichous Chao et al., 2008  
L. curvatus NRIC 0822 Kabura-zushi, a Japanese 
fermented food 
Peritrichous Cousin et al., 2015  
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The characteristics of Lactobacillus flagella are poorly known, with only a few published studies mainly 
focusing on immunomodulatory effects. In one study, flagellins isolated from L. ruminis ATCC 27782, L. 
nagelii DSM 13675, Lactobacillus mali DSM 20444, and Lactobacillus ghanensis L489 induced IL-8 
production in HT-29 cells via the TLR5-dependent signaling pathway (Neville et al., 2012). In another study, 
depolymerized flagellar filaments from Lactobacillus agilis BKN88 stimulated TLR5-modulated IL-8 
production in Caco-2 cells to a degree that was much lower than that induced by the same amount of 
Salmonella flagellins, whereas whole L. agilis BKN88 cells did not have immune stimulating effects 
(Kajikawa et al., 2016). 
2.3.1.3 Lactobacillus rhamnosus GG 
L. rhamnosus GG is one of the best-studied lactobacilli, with many proven beneficial effects, and has been 
used as a probiotic for almost three decades. It was originally isolated from a stool sample of a healthy human 
in the 1980s, with desirable characteristics including resistance to gastric acid and bile, adherence to human 
IECs, the production of an antimicrobial agent, and an appreciable growth rate (Goldin and Gorbach, 1984). 
Since then, it has been attracting increasing attention. It has been used in dairy products since 1990 (Salminen 
et al., 2002) and has rapidly become a popular probiotic in the food industry and pharmacies worldwide. After 
discontinuing the consumption, probiotic L. rhamnosus GG can be identified in most stool samples for 4 days 
and in 33% of the samples up to 7 days; however, even though its existence is prolonged in human colonic 
mucosae, it ultimately disappears (Goldin et al., 1992; Alander et al., 1999). Therefore, it has been regarded 
as an allochthonous member of the gut microbiota. However, EPS (Lebeer et al., 2011) and mucus-specific 
adhesins, such as pili, the mucus-binding factor (von Ossowski et al., 2011), and the modulator of adhesion 
and biofilm (MabA) protein (Velez et al., 2010), appear to prolong the gastrointestinal retention time of L. 
rhamnosus GG. 
2.3.1.3.1 L. rhamnosus GG pili  
The presence of pili in L. rhamnosus GG was first observed in 2009: a comparative genomic analysis revealed 
two pilus gene clusters (spaCBA and spaFED) in the genome (Kankainen et al., 2009). SpaCBA and SpaFED 
pili in L. rhamnosus GG are each composed of three different pilin subunit types. SpaA (31 kDa) or SpaE (45 
kDa) builds up the backbone of the pilus fiber, SpaB (21 kDa) or SpaD (51 kDa) forms the pilus base, and 
SpaC (91 kDa) or SpaF (104 kDa) is positioned at the pilus tip (Kankainen et al., 2009; von Ossowski et al., 
2010). Each pilin except for SpaE has an LPXTG-like motif and an E-box, and an YPKN pilin motif was found 
in SpaA, SpaB, and SpaD (Kankainen et al., 2009). For the SpaCBA pili, the ratio of each pilin 
(SpaA:SpaB:SpaC) is 5:2:1, as analyzed by mass spectrometry (Tripathi et al., 2013). Reunanen et al. (2012) 
clearly demonstrated in their study that there were 10 to 50 pili per L. rhamnosus GG cell, the length of a pilus 
was up to 1 μm, and SpaC was located at the tip and along the pilus shaft. Subsequently, the existence of 
SpaCBA pili was further confirmed by immuno-TEM with SpaA and SpaB antisera. A comparative analysis 
of the L. rhamnosus pan-genome revealed that all 13 tested strains possessed the spaFED operon, which was 
categorized as belonging to the core genome, while only the genomes of four strains (including L. rhamnosus 
GG) in L. rhamnosus species harbored the spaCBA loci (Kant et al., 2014). However, thus far, native 
expression of SpaFED pili has not been demonstrated in any L. rhamnosus strain in vitro.  
Functional properties of SpaCBA pili 
The SpaCBA pili have been well characterized. The major feature is adhesiveness, such as binding to the 
human intestinal epithelial cell line Caco-2 and human intestinal mucus (Lebeer et al., 2012; von Ossowski et 
al., 2013), which probably facilitates L. rhamnosus GG residence in the GIT. The SpaC pilin subunit exhibits 
a strong binding capacity to human intestinal mucus; in contrast, this binding ability of L. rhamnosus GG is 
almost completely abolished when L. rhamnosus GG is pretreated with SpaC antiserum or when it carries an 
inactivated spaC gene (Kankainen et al., 2009). Furthermore, the SpaC pilin subunit adheres to Caco-2 cells, 
porcine type II mucin, type I collagen, and murine intestinal epithelia (Lebeer et al., 2012; Tripathi et al., 2013; 
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Ardita et al., 2014). A subsequent study showed that, in addition to SpaC, the recombinant SpaB pilin protein 
expressed in E. coli also binds significantly to human intestinal mucus; however, the mucus-binding property 
of L. rhamnosus GG pretreated with SpaB antiserum was not affected, indicating that the binding of SpaB to 
mucus was mediated by non-specific electrostatic interactions rather than by the presence of specific binding 
sites (von Ossowski et al., 2010). The recombinantly expressed SpaA pilin subunit lacked the capacity to 
adhere to human intestinal mucus (von Ossowski et al., 2010). Taken together, the SpaC pilin subunit was an 
indispensable and dominant adhesive factor in L. rhamnosus GG. Nevertheless, it is worthwhile to mention 
that in addition to SpaC, other adhesins such as MabA and mucus binding factor also contribute to the adhesion 
of L. rhamnosus GG to mucus (Velez et al., 2010; von Ossowski et al., 2011). Notably, SpaCBA pili also take 
part in biofilm formation in a SpaC-dependent way; one possible mechanism is that the SpaC–SpaC 
interactions (homophilic adhesion) lead to bacterial aggregation, which contributes to biofilm formation 
(Lebeer et al., 2012; Tripathi et al., 2013).  
In addition to adhesion, another important feature of SpaCBA pili is their immunomodulatory effect. A mutant 
lacking SpaCBA pili induces an elevated level of proinflammatory cytokine IL-8 mRNA expression in Caco-
2 cells as compared to the wild type L. rhamnosus GG (Lebeer et al., 2012). Conversely, a recombinant 
lactococcal strain producing SpaCBA pili activates TLR2-dependent signaling, which leads to NF-κB 
induction and IL-8 production in HEK293 cells, and upregulates the production of pro- and anti-inflammatory 
cytokines (TNF-α, IL-6, IL-10, and IL-12) in moDCs (von Ossowski et al., 2013). The dampening and boosting 
immunological effects of SpaCBA pili may somehow be balanced within the gut and thus promote the 
maintenance of gut immune homeostasis. 
Functional properties of SpaFED pili 
In comparison to SpaCBA pili, studies on the function of SpaFED pili were sparse before this thesis work, 
probably due to the fact that the native expression of SpaFED in L. rhamnosus GG or other lactobacilli has not 
yet been observed under laboratory conditions. However, the existence of SpaFED pili in L. rhamnosus GG in 
the GIT cannot be excluded, either. Of the three pilin subunits of L. rhamnosus GG that have been 
recombinantly expressed in E. coli, only SpaF was shown to have the potential to adhere to human intestinal 
mucus, at a level similar to SpaC (von Ossowski et al., 2010).  
2.3.1.3.2 L. rhamnosus GG contributes to gastrointestinal well-being 
The consumption of probiotics is a safe and effective way to generate beneficial effects in the host intestine. 
Numerous studies have demonstrated that L. rhamnosus GG exhibits health-promoting effects, such as effects 
on dental health (Näse et al., 2001), allergic diseases (Peldan et al., 2017), and especially on the maintenance 
of gastrointestinal health, including the fortification of the intestinal barrier and combatting of GIT disorders.  
First of all, L. rhamnosus GG is able to promote the intestinal barrier function in many pathological states. For 
example, alcohol treatment of Caco-2 cells dislocates and decreases the expression of tight junction proteins 
(e.g., ZO-1, claudin-1 and occludin), whereas such pathogenic effects are completely prevented in Caco-2 cells 
that are pre-treated with the L. rhamnosus GG culture supernatant (Wang et al., 2011). In another example, L. 
rhamnosus GG culture supernatant elevates the production of mucin, IgA, and ZO-1 in the neonatal rat 
intestine, through which intestinal damage caused by E. coli K1 is prevented (He et al., 2017). Other animal 
studies have further strengthened this notion by showing that L. rhamnosus GG decreases gut permeability 
caused by alcohol consumption, thus preventing endotoxemia and ameliorating liver damage in a rat model 
(Forsyth et al., 2009; Wang et al., 2011).  
Furthermore, L. rhamnosus GG has anti-inflammatory activities in vitro and in vivo. In vitro studies performed 
on human intestinal epithelial cells have indicated that L. rhamnosus GG suppresses IL-8 production induced 
by TNF-α and E. coli K88, in part as a result of the blockage of NF-κB nuclear translocation and/or the 
inhibition of pathogen adhesion (Zhang et al., 2005; Roselli et al., 2006; Donato et al., 2010). In a mouse model, 
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L. rhamnosus GG has been demonstrated to upregulate the mRNA of IL-10R2 (a subunit of IL-10 receptor), 
thereby attenuating the concentrations of pro-inflammatory cytokines (e.g., TNF-α and macrophage 
inflammatory protein (MIP)-2) in the immature colon and protecting mice from intestinal damage induced by 
inflammatory factors (e.g., platelet activating factor and LPS) (Mirpuri et al., 2012). Additionally, mice 
infected with Pseudomonas aeruginosa showed elevated mRNA levels of pro-inflammatory cytokines, 
including IL-6, IL-1β, and TNF-α, whereas L. rhamnosus GG treatment significantly down-regulated these 
levels in the colon (Khailova et al., 2016).  
L. rhamnosus GG has been shown to modulate the composition of the gut microbiota. A 16S rRNA gene 
sequencing analysis revealed that L. rhamnosus GG suppressed the pathogenic expansion of the members of 
Proteobacteria and Actinobacteria in mice fed with alcohol, thereby preventing epithelial barrier disruption, 
endotoxemia, and liver damage (Bull-Otterson et al., 2013). Additionally, human intervention trials have 
further proved that L. rhamnosus GG is able to modulate the gut microbiota composition. When infants with 
cow’s milk allergy were treated with extensively hydrolyzed casein formula and L. rhamnosus GG, they 
acquired tolerance towards cow’s milk, whereas control infants who were only supplemented with extensively 
hydrolyzed casein formula remained allergic (Canani et al., 2015). In most tolerant infants, the amount of fecal 
butyrate was significantly increased, which was associated with significantly increased gut butyrate-producing 
bacteria, such as the genera Blautia and Roseburia (Canani et al., 2015). In another study applying a 
metagenomics approach, L. rhamnosus GG was shown to alter and protect the gut microbiota against antibiotic 
disturbance in children (Korpela et al., 2016): long-term L. rhamnosus GG consumption increased the quantity 
of species related to Lactobacillus, Lactococcus, Prevotella, and Ruminococcus, but decreased the amount of 
species related to E. coli, Eubacterium cylindroides, and Clostrium ramosum. Penicillin treatment enriched 
potential pathogens, including Clostridium cluster I and relatives of Clostridium difficile; nevertheless, such 
pathological effects were normalized by L. rhamnosus GG (Korpela et al., 2016). 
Based on effects such as those described above, L. rhamnosus GG has been widely used to prevent and treat 
GIT disorders in humans, with promising outcomes. Early in 1987, L. rhamnosus GG showed the potential to 
prevent the relapse of Clostridium difficile colitis (Gorbach et al., 1987). Later, L. rhamnosus GG also 
effectively prevented the relapse of ulcerative colitis (Zocco et al., 2006). In placebo-controlled trials, the 
administration of L. rhamnosus GG has prevented and enhanced the treatment of antibiotic- and healthcare-
associated diarrhea (e.g. rotavirus gastroenteritis) (Isolauri et al., 1991; Kaila et al., 1995; Arvola et al., 1999), 
reduced nosocomial gastrointestinal and respiratory tract infections (Hojsak et al., 2010), and alleviated the 
symptoms of IBS (Pedersen et al., 2014). 
2.3.1.4 Lactobacillus ruminis  
L. ruminis belongs to the L. salivarius clade (Sharpe et al., 1973). Members of this clade have usually 
originated from food and the environment, as well as the mammalian GIT, and several species in this clade 
can be regarded as candidate probiotics due to their beneficial properties, such as immunomodulatory effects 
and pathogen inhibition (Neville and O'Toole, 2010). Of the 25 species in this clade (Neville and O'Toole, 
2010), L. ruminis is one of the poorly characterized members. It was first isolated in 1960 from the stool sample 
of a healthy human (Lerche and Reuter, 1960), and later from the rumen contents of a cow (Sharpe et al., 1973), 
the large intestinal contents of pigs (Al Jassim, 2003), horse feces (Willing et al., 2009), and the bovine uterus 
(Gärtner et al., 2015). An increasing number of new isolates have been identified in different mammalian hosts, 
including humans (Yun et al., 2005; O’Donnell et al., 2015). Due to its consistent identification in the 
mammalian intestine and feces, L. ruminis has been considered as one of the few autochthonous Lactobacillus 
species in the GIT (Tannock et al., 2000; Reuter, 2001). It has evolved to adapt to the GIT environment, as it 
has, for instance, the potential for anaerobic respiration (Kant et al., 2017). 
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The autochthony of L. ruminis could be explained by its stress survival, carbohydrate utilization, and intestinal 
colonization. A recent study demonstrated that 16 L. ruminis strains of human, porcine, bovine, and equine 
origin are resistant to porcine bile, and most strains are able to grow in simulated gastric fluid with a low pH 
and digestive enzymes (O’Donnell et al., 2015), indicating that L. ruminis is able to survive in the intestine. 
Moreover, L. ruminis exhibits metabolic versatility. Thereby, it can obtain energy via various sources and may 
have growth benefits over some other gut microbes in the nutritionally competitive intestine. L. ruminis strains 
show abilities to metabolize diverse carbohydrates to varying degrees, including monosaccharides and non-
digestible oligosaccharides, which are rich in the colon (O’Donnell et al., 2011; O’Donnell et al., 2015). A 
recent pan-genome study provided additional data about the above findings. In this study, the analysis of the 
core genome of 9 L. ruminis strains revealed that it can synthesize indispensable enzymes for fermentation via 
the phosphoketolase pathway, suggesting that L. ruminis has the potential to utilize hexose and pentose 
carbohydrates (Kant et al., 2017). Therefore, it was concluded that L. ruminis may use both homofermetative 
and heterofermentative pathways to widen its repertoire of energy sources (Kant et al., 2017). Additionally, in 
de Man-Rogosa-Sharpe (MRS) medium supplemented with glucose, lactose, or sucrose, 16 L. ruminis strains 
of different origins had varying abilities to produce EPS (O’Donnell et al., 2015). Specifically, 3 human, 1 
porcine, and 2 bovine strains produced EPS under these three conditions, whereas 4 strains, including one 
bovine isolate (ATCC 27782), did not synthesize EPS at all (O’Donnell et al., 2015), even though a gene 
cluster for EPS production was detected in the genome of this bovine isolate genome (Forde et al., 2011). 
However, the possibility to synthesize EPS in vivo or with other carbon sources could not be ruled out, as in 
the species L. salivarius (Raftis et al., 2011), EPS production largely relies on the growth conditions, including 
carbohydrate availability. Furthermore, the genome of this bovine strain contained genes encoding a 
bacteriocin, as well as accessory proteins and proteins related to bacteriocin immunity and regulation, whereas 
bacteriocin activity has not been reported in this strain so far (Forde et al., 2011). In contrast, the human strain 
ATCC 25644 lacks genes for bacteriocin peptides and the transport apparatus (Forde et al., 2011).  
Microbial surface structures are pivotal in mediating microbe–host interactions and essential for the microbe 
to prevail in an ecological niche. Genes encoding sortase A and C, and LPXTG motif-containing proteins 
including sortase-dependent pili were identified in the genomes of L. ruminis ATCC 25644 isolated from a 
human, and in ATCC 27782 of bovine origin; the transcription of the pilus genes was remarkably up-regulated 
in the human strain compared to that in the bovine strain, when they were anaerobically cultivated in MRS for 
15 h (Forde et al., 2011). Additionally, 7 other L. ruminis strains with human, bovine, porcine, and equine 
origins were predicted to have pilus genes and to express sortase-dependent surface proteins containing an 
intact LPXTG domain, indicating that these strains have the potential to express pili (Kant et al., 2017). 
In addition to pili, flagella also probably contribute to L. ruminis autochthony. With the potential to display 
flagella, L. ruminis could reach nutrient-rich locations and epithelial cells by penetrating the mucus layer, thus 
outcompeting other gut microbes and prolonging the gut retention time via adhesion by pili or other surface 
proteins. An early study by Sharpe et al. (1973) clearly demonstrated that certain L. ruminis strains were 
flagellated, as examined by EM. Subsequently, motility genes involved in flagellar assembly and chemotaxis 
have been found in the genomes of many L. ruminis strains, including isolates of human, bovine, porcine, and 
equine origin (Forde et al., 2011; Neville et al., 2012; Lawley et al., 2013; Kant et al., 2017). Human L. ruminis 
was observed to be motile as early as in the 1960s (Lerche and Reuter, 1960), but motility has not subsequently 
been detected, despite a complete set of flagellar biogenesis genes being found in the genomes of some strains, 
including ATCC 25644 (Forde et al., 2011; Neville et al., 2012). In contrast, other mammalian-sourced L. 
ruminis strains are motile (Neville et al., 2012; O’Donnell et al., 2015). Of the 16 mammalian strains studied 
by O’Donnell et al. (2015), 10 were able to swarm on solid agar plates; among them, porcine and equine 
isolates possessed more flagella on a single bacterium, and were thereby more motile than bovine isolates 
(O’Donnell et al., 2015). Nevertheless, some bacterial cells of the human non-motile strain ATCC 25644 are 
able to perform a tumbling movement after passing through the murine GIT (Neville et al., 2012). Importantly, 
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flagella are typical MAMPs that can be recognized by PRRs of the host cells and thus can induce inflammatory 
cytokine production. As an example, the recombinantly expressed flagella of ATCC 25644 produced in E. coli, 
flagella purified from ATCC 27782, and also flagellated ATCC 27782 bacterial cells promote IL-8 secretion 
through the TLR5 signaling pathway in various cell lines (Neville et al., 2012).  
Considering the probiotic potential of L. ruminis, its putative immunomodulatory and anti-pathogen properties 
are of interest. L. ruminis has been reported to promote the production of TNF in vitro (Taweechotipatr et al., 
2009), and activate the NF-κB pathway in the human monocyte cell line THP-1 (Taweechotipatr et al., 2009). 
In addition, L. ruminis SPM0211 inhibited the growth of antibiotic-resistant pathogens (vancomycin 
intermediate-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus) in a co-culture-based 
assay (Yun et al., 2005). In a later study, L. ruminis SPM0211 was found to inhibit the growth of rotavirus in 
Caco-2 cells and in the GIT of neonatal mice, in which significantly upregulated IFN-α/β levels were detected 
(Kang et al., 2015). Considering the probiotic potential, however, several strains, especially human isolates, 
are not applicable due to their susceptibility to an acidic pH (O’Donnell et al., 2015). 
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3. Aims of the study 
Members of the gut microbiota live permanently (autochthonous species) or survive for a certain period of 
time (allochthonous species) in the harsh GIT conditions. L. ruminis, a motile species and one of the few 
autochthonous Lactobacillus in the mammalian gut, is poorly investigated. In contrast, L. rhamnosus GG, an 
allochthonous bacterium, is a popular and broadly used probiotic. The SpaCBA pili of L. rhamnosus GG have 
been investigated thoroughly. However, the properties of its SpaFED pili are largely unknown. Therefore, we 
chose these two species, representing different types of gut residence, and phenotypically characterized their 
pili. Subsequently, we also analyzed other niche-adaptive factors of L. ruminis (e.g. pathogen inhibition) and 
other interactions of L. ruminis with the host. The specific aims of this study were: 
? To phenotypically characterize the SpaFED pili of L. rhamnosus GG, recombinantly expressed in 
Lactococcus lactis (I); 
 
? To phenotypically characterize the LrpCBA pili of L. ruminis, recombinantly expressed in 
Lactococcus lactis (II); 
 
? To investigate the adhesive, pathogen inhibitory and immunomodulatory functions of four L. ruminis 
strains of different mammalian origin (III). 
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4. Materials and methods  
The plasmid, bacterial strains, cells and adhesion targets used in this study are listed in Table 3. The 
experimental methods are summarized in Table 4. The detailed culture conditions and methodological 
descriptions are presented in the articles. 
 
Table 3. Plasmid, strains, cells, and proteins used in this work 
 Plasmid, strain, cell, or protein Origin and/or reference Study 
Plasmid  pKTH5080: a pNZ8032-derived expression 
vector containing a nisin-inducible promoter 
von Ossowski et al., 2013  I, II 
 
 
 
 
 
 
 
 
 
Lactic acid 
bacteria 
 
 
 
 
 
 
 
 
 
 
 
L. rhamnosus GG Human  I 
L. ruminis ATCC 25644 Human  II,III 
L. ruminis ATCC 27780 Bovine  III 
L. ruminis ATCC 27781 Bovine  III 
L. ruminis GRL1172 Pig (this study) III 
GRS71: Lactococcus lactis NZ9000  De Ruyter et al., 1996  I, II 
GRS1052: L. lactis NZ9000 + pKTH5080  von Ossowski et al., 2013  I, II 
GRS1224: L. lactis NZ9000 + pKTH5080  
with lrpCBA of L. ruminis ATCC 25644 
This study II 
GRS1225: L. lactis NZ9000 + pKTH5080 
with lrp∆CBA of L. ruminis ATCC 25644    
This study II 
GRS1189: L. lactis NZ9000 + pKTH5080 
with spaFED of L. rhamnosus GG 
This study I 
GRS1226: L. lactis NZ9000 + pKTH5080 
with spa∆FED of L. rhamnosus GG  
This study I 
GRS1185: L. lactis NZ9000 + pKTH5080 
with spaCBA of L. rhamnosus GG 
von Ossowski et al., 2013  II 
GRS1211: L. lactis NZ9000 + pKTH5080 
with spa∆CBA of L. rhamnosus GG 
von Ossowski et al., 2013  II 
 
 
 
Pathogens 
Escherichia coli ETEC (F4+) 
E. coli ATCC 43894 (EHEC, O157) 
E. coli ERF 2014 (F18+, O141) 
Salmonella enterica serotype typhimurium 
ATCC 14028 
Yersinia enterocolitica DSM 13030 
Listeria monocytogenes ATCC 19117 
Pig, Roselli et al., 2007  
Human  
Pig, Hynönen et al., 2014    
Chicken 
 
Human  
Sheep  
III 
III 
III 
III 
 
III 
III 
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Table 3. Plasmid, strains, cells, and proteins used in this work (continued) 
 Plasmid, strain, cell, or protein Origin or reference Study 
 
 
 
 
Cells 
HT-29 Human colorectal 
adenocarcinoma 
(ECACC) 
I, II, III 
Caco-2 Human colon 
adenocarcinoma (ATCC) 
I, II, III 
IPEC-1 Porcine small intestinal 
epithelium (DSMZ) 
III 
moDCs Human monocytes 
(Finnish Red Cross)  
I, II 
HEK293-TLR2 cells Human embryonic 
kidney, engineered 
(InvivoGen, USA) 
I, II, III 
HEK293-TLR5 cells Human embryonic 
kidney, engineered 
(InvivoGen) 
I, II, III 
Other substrates 
for adhesion 
assays 
ECM proteins: fibronectin, collagen type I and 
IV 
Human I, II, III 
Type II mucin Pig  I, II 
 
 
Table 4. Methods used in this study 
Methods Study 
DNA manipulation 
and analysis 
Construction of recombinant L. lactis strains  I, II 
Sequencing and sequence comparisons III 
Analysis of 
bacterial surface 
structures 
Nisin-induced expression of pilus genes in recombinant L. 
lactis 
I, II 
Western blotting I, II 
Electron microscopy I, II, III 
Biofilm formation assay II 
Adhesion assays Adherence to intestinal epithelial cell lines I, II, III 
Adherence to porcine mucin I, II 
Adherence to extracellular matrix proteins I, II, III 
Pathogen inhibition 
assays  
Inhibition of pathogen growth by L. ruminis supernatants III 
Inhibition of pathogen adherence by L. ruminis to 
intestinal epithelial cells and ECM proteins 
III 
Barrier function 
analysis  
Measurement of paracellular permeability and TEER  III 
Immunofluorescence assay of TJ proteins III 
Analysis of 
immunomodulatory 
effects  
Stimulation of HEK-TLR2/TLR5 cells I, II, III 
Measurement of IL-8 production in Caco-2 cells I, II 
Measurement of cytokine production in moDCs  I, II 
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5. Results and discussion 
The structural and functional traits of the studied L. rhamnosus GG SpaFED pili and L. ruminis LrpCBA pili 
are summarized in Table 5 and elaborated more closely in the later sections. The adhesiveness of SpaFED and 
LrpCBA pili most likely reflects the gut adaptation of these two bacterial species. Moreover, other features of 
L. ruminis, such as its ability to inhibit pathogens and to maintain barrier function in epithelial cells, suggest 
that this autochthonous species has a mutualistic relationship with the host. However, further in vivo studies 
are needed. 
Table 5. Features of SpaFED pili in L. rhamnosus GG and LrpCBA pili in L. ruminis 
  SpaFED pili of L. rhamnosus 
GG 
LrpCBA pili of L. ruminis 
Native expression Not yet detected  
 
Recombinant expression in 
L. lactis 
  
Pilin subunits SpaD (major), SpaE (basal), and 
SpaF (tip, adhesin) 
LrpA (major), LrpB (basal), and 
LrpC (tip, adhesin) 
Pilus biogenesis  Sortase-dependent assembly Sortase-dependent assembly 
Adhesion to mucus + - 
Adhesion to ECM proteins fibronectin, collagen type I and IV  fibronectin, collagen type I and IV 
Adhesion to IECs HT-29, poorly to Caco-2 HT-29, Caco-2 
Biofilm formation No contribution No contribution 
Immunomodulation Immune-dampening effect in 
HEK-TLR2 and Caco-2 cells 
Immune-dampening effect in 
HEK-TLR2 and Caco-2 cells 
5.1 In silico analysis of the lrpCBA operon (II) 
To determine whether L. ruminis ATCC 25644 possesses pilus-encoding genes, its genome sequence data 
obtained from the NCBI database were analyzed. Scrutiny of the genome revealed that L. ruminis ATCC 25644 
contains a pilus gene cluster (nucleotide position 23941 to 31363) that encodes three pilin subunits (LrpA, 
LrpB, and LrpC) and one sortase C class enzyme. Each pilus gene has the sequence for a ribosomal binding 
site and encodes an E-box domain (Figure 1 in II). Moreover, an N-terminal secretion signal and an LPXTG-
like sortase recognition motif at the C-terminal domain were found in each predicted pilin protein, but only 
the predicted LrpA and LrpB proteins possessed a pilin motif. Additionally, a predicted collagen-binding 
domain was identified only in LrpC pilin, while no sequences encoding mucus-binding domains were found 
in the L. ruminis ATCC 25644 genome. BlastP analysis revealed that each pilin of L. ruminis ATCC 25644 
shows the highest amino acid identity to the counterpart pilins from other L. ruminis strains. Sequence 
alignment of the lrpC genes of five L. ruminis strains from different origins, including ATCC 25644, revealed 
that these gene operons are highly similar with an identical ribosomal binding site and two consensus promoter 
elements. However, the similarities in amino acid sequences between L. ruminis ATCC 25644 and lactobacillar 
SpaCBA or SpaFED pilins were not very high. These results suggest that the lrpCBA pilus operon might be 
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specific to L. ruminis species, unlike spaCBA and spaFED operons, which can be found in many lactobacilli 
(Kankainen et al., 2009; Muñoz-Provencio et al., 2012; Smokvina et al., 2013).  
5.2 Surface structures of L. ruminis revealed by Western blotting and TEM (II, III) 
To detect native pilus expression on L. ruminis, Western blotting was first employed, as it is a widely used 
approach to detect bacterial pilin production. Each of the anti-pilin sera, including anti-LrpA, anti-LrpB, and 
anti-LrpC, detected ladder-like bands when membranes blotted with L. ruminis ATCC 25644 cells were probed, 
suggesting the presence of monomeric pilins as well as truncated and wall-attached LrpCBA pili of different 
sizes (Figure 3A in II). Indeed, as pili in Gram-positive bacteria are made of covalently linked adhesive pilin 
subunits, high-molecular-weight (HMW) bands are interpreted as pili of different lengths in Western blots 
(Reunanen et al., 2012). In contrast, no bands were observed when L. rhamnosus GG was used as the negative 
control.  
Subsequently, immuno-TEM was applied to examine the surface display of LrpCBA pili. With single labeling, 
using antiserum against the backbone pilin (LrpA) of L. ruminis ATCC 25644, pilus shafts of different lengths 
were clearly observed (Figure 3B top left panel in II). These pili of different lengths were either broken or 
attached to the bacterial surface. Generally, most bacterial cells were piliated, while cells without pili were 
also observed. Notably, even though the LrpA antiserum was specifically generated against the ATCC 25644 
LrpA pilin proteins, it could also be used to confirm the presence of pili in GRL1172 (our unpublished results). 
Thus, it is evident that the main pilus subunits of these two L. ruminis strains with different origins share 
structural similarity. In contrast, anti-LrpA antibodies did not detect L. rhamnosus GG pili (Figure 3B top right 
panel in II), demonstrating that the main subunit of L. ruminis pilus is distinct from that of L. rhamnosus GG.  
To further determine the positions of other pilin subunits, double labeling was performed. When L. ruminis 
ATCC 25644 and porcine L. ruminis GRL1172 bacteria were treated with anti-LrpA and anti-LrpC antibodies, 
LrpC pilins were found at the pilus tip, as well as along the pilus shaft (Figure 3B bottom left panel in II and 
Figure 1B in III), which was reminiscent of the position of the tip pilin SpaC in SpaCBA pili of L. rhamnosus 
GG (Kankainen et al., 2009; Reunanen et al., 2012). It has been reported that the recognizable pilin motif is 
absent from the SpaC pilin, which makes it impossible to integrate it into the pilus backbone (Reunanen et al., 
2012). However, its putative two E box motifs or other unidentified systems might account for its incorporation 
in the pilus fiber (Reunanen et al., 2012). In L. ruminis labeled with anti-LrpA and anti-LrpB antibodies, the 
pilus shaft was dominated by the LrpA pilin, while the basal pilin LrpB subunits were also present on the pilus 
backbone (Figure 3B bottom right panel in II). In conclusion, the TEM results of this study have thus revealed 
that L. ruminis is a piliated Lactobacillus species.  
So far, L. ruminis has been considered as the only motile autochthonous Lactobacillus species in the human 
gut microbiota (Neville et al., 2012). A bioinformatics analysis identified genes encoding flagella in the 
genomes of ATCC 25644 and the bovine L. ruminis strain ATCC 27782, but the expression of flagella was 
only confirmed in the latter (Neville et al., 2012). Therefore, ATCC 25644 was regarded as aflagellated by 
these authors. Conversely, we found by EM that ATCC 25644 (Figure 6, our unpublished result) as well as 
GRL1172 (Figure 1A in III), when they were grown on MRS agar plates for 2 days, have flagella. ATCC 
25644 possessed a single flagellum, while GRL1172 cells had one or several flagella. However, aflagellated 
cells of both strains were also present. Considering the harsh conditions of the GIT, being motile could confer 
many competitive advantages to autochthonous L. ruminis, as flagella are able to propel the bacteria towards 
nutrient-rich environments and other favorable colonization niches. 
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Figure 6. Visualization of flagella in L. ruminis 
ATCC 25644. Negative staining of L. ruminis 
cells. The black arrowhead indicates a flagellum. 
 
5.3 Expression of L. rhamnosus GG SpaFED and L. ruminis LrpCBA pili in Lactococcus lactis 
(I, II) 
To study the phenotypic characteristics of L. rhamnosus GG SpaFED and L. ruminis LrpCBA pili, the spaFED 
or lrpCBA operon was cloned into the nisin-dependent expression vector pKTH5080, and the recombinant 
plasmids were transformed into Lactococcus lactis NZ9000. The resulting recombinant strains were then 
named as GRS1189 or GRS1224, respectively. This cloning method has also been used to investigate other 
pilus types in Gram-positive bacteria (Buccato et al., 2006; Quigley et al., 2010; Oxaran et al., 2012), including 
L. rhamnosus GG SpaCBA pili (von Ossowski et al., 2013). To better understand the role of the tip pilin 
subunits, we also constructed recombinant lactococcal clones expressing Spa∆FED or Lrp∆CBA pili without 
the tip pilin, termed as GRS1226 or GRS1225, respectively. To verify pilus expression in these recombinants, 
Western blotting was first conducted, followed by TEM. After nisin induction, the sonicated recombinant 
lactococcal cells were analyzed by immunoblotting with anti-pilin antibodies. Clear ladder-like protein bands 
appeared when sonicated GRS1189 and GRS1224 cells were immunoblotted with each of the SpaFED- (anti-
SpaF, anti-SpaE and anti-SpaD) and LrpCBA-specific (anti-LrpC, anti-LrpB and anti-LrpA) antisera, 
respectively (Figure 4 in I and Figure 4B in II). Bands representing the monomeric pilins were obviously 
present: SpaD~51 kDa, SpaE~45 kDa, SpaF~104 kDa, LrpA~49 kDa, LrpB~39 kDa, LrpC~123 kDa. These 
results evidently demonstrated that SpaFED and LrpCBA pili can be expressed in lactococci. GRS1226 and 
GRS1225 were also proved to express backbone and basal pilins, but not tip pilins. As expected, the anti-pilin 
antibodies did not detect anything on polyvinylidene difluoride membranes blotted with sonicated L. lactis 
cells carrying the vector control without insert (GRS1052) (Figure 4 in I and Figure 4B in II). 
We further applied TEM to visualize the recombinantly expressed SpaFED and LrpCBA pili in L. lactis in the 
same way as TEM was used to detect native LrpCBA pili in L. ruminis ATCC 25644. For L. rhamnosus GG 
SpaFED pili, nisin-induced GRS1189 (Figure 5A in I) and GRS1226 (Figure 5E in I) were single-labeled with 
anti-SpaD antibodies, and pilus structures were evidenced by black dots along the dense lines extending out 
from the cell wall surface. No pilus-like structures were detected in Lactococcus lactis NZ9000, used as the 
negative control (GRS71), when it was incubated with anti-SpaD, as shown in Figure 5B in I. Subsequently, 
double labeling was carried out using antibody pairs that detected either SpaD and SpaF pilins (Figure 5C and 
F in I) or SpaD and SpaE pilins (Figure 5D and G in I). In GRS1189, SpaF pilin was not only found at the 
pilus tip, but also along the shaft in a manner similar to the basal SpaE pilin. Such an assembly of minor pilins 
has also been observed in other pilus types in Gram-positive bacteria, such as in the SpaCBA pili in 
Corynebacterium diphtheriae (Mandlik et al., 2008a) and L. rhamnosus GG (Reunanen et al., 2012). In 
GRS1126, SpaF pilin was not present at the pilus tip as expected, but appeared on the pilus backbone. This 
result was not consistent with the Western blotting observation, where SpaF could not be detected in GRS1226 
with anti-SpaF antibodies. This discrepancy suggests that anti-SpaF antibodies cross-react with the backbone 
pilin SpaD, and thus SpaF pilin, seemingly attaching to the pilus fiber, was a TEM artifact. It is worth 
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mentioning that pili in GRS1226 were much longer and occasionally more abundant per bacterium compared 
with those in GRS1189. One possible explanation is that the lack of the spaF gene results in the upregulation 
of the expression of the spaD, spaE and sortase-encoding genes. 
Immuno-TEM was also applied to detect LrpCBA pili of L. ruminis on recombinant lactococci. After treatment 
with anti-LrpA antibodies, pili were clearly visible in GRS1224 and GRS1225 cells, whereas pili-like 
structures were not observed in GRS71, as expected (Figure 4C in II). Double labeling with anti-LrpA 
antibodies coupled with antibodies targeting LrpC or LrpB pilins revealed that pili were evidently exhibited in 
GRS1224 and GRS1225 (Figure 4C middle and bottom panels in II). As observed in the case of SpaF 
immunostaining of the deletion mutant GRS1226, LrpC subunits were observed on the pilus fiber of GRS1225 
by TEM, although they were not detected by Western blotting with anti-LrpC antibodies. Then again, we 
considered such a phenomenon to be an artifact. Since there was a heavy background in some TEM images 
(Figure 4C in II), GRS1224 and GRS1225 were incubated with the corresponding pre-immune serum, and 
only a negligible background appeared (S4 Fig in II). These results indicated that the gold particles in the 
background (Figure 4C in II) were indeed due to specific antibody binding to pilus fragments. However, as the 
recombinant pili were longer than the native ones, they might have been fractured more easily. The broken pili 
were then recognized by specific antibodies, which seemed to be difficult to wash off, and this binding possibly 
formed the background.  
5.4 Adhesion of L. rhamnosus GG SpaFED pili and Lactobacillus ruminis (I, II, III) 
The intestinal barrier, including mucus and the epithelial layer, largely confines bacteria in the lumen and 
inhibits their invasion. The capacity of gut-resident microbes to adhere to host cells or tissues is regarded as 
niche-adaptation, as it facilitates host colonization either permanently or transiently. Mucin (or mucus), 
epithelial cells, and ECM proteins are usually used as substrates to assess bacterial adhesiveness.   
5.4.1 Adhesion capacity of L. rhamnosus GG SpaFED pili (I) 
As an allochthonous bacterium, L. rhamnosus GG utilizes its certain structural components, including EPS 
(Lebeer et al., 2011), mucus-binding factor (von Ossowski et al., 2011), MabA (Velez et al., 2010), and 
SpaCBA pili (von Ossowski et al., 2013), to extend its transient colonization of the GIT. As previously reported, 
the recombinantly expressed SpaF pilin subunit binds to human mucus as strongly as SpaC pilin protein (von 
Ossowski et al., 2010). To characterize the putative SpaFED pili, we tested their adhesion abilities and the 
contribution of SpaF subunits to adhesion using a lactococcal display system in L. lactis. Similarly to the 
recombinant SpaCBA pili, which adhered to human intestinal mucus (von Ossowski et al., 2013), L. lactis 
GRS1189 expressing SpaFED pili strongly bound to porcine mucin, whereas GRS1226 lacking the tip pilin 
SpaF showed a much weaker adhesion (Figure 6 in I). As the negative controls, GRS71 and GRS1052 showed 
no or negligible adherence to mucin. Thereby, the determining role of SpaF in mediating the mucin binding of 
SpaFED was confirmed.  
ECM, composed of several proteins such as fibronectin and collagen, is located beneath epithelial cells. These 
ECM proteins are exposed in the damaged host mucosa and may thus promote microbial colonization (Štyriak 
et al., 2003). Pilus-mediated ECM adhesion has been reported in various Gram-positive bacteria (Telford et 
al., 2006; Hilleringmann et al., 2008). For instance, the L. rhamnosus GG pilus SpaC subunit binds to collagen 
(Tripathi et al., 2013). Accordingly, the adhesiveness of SpaF to ECM proteins was investigated using the 
lactococcal expression system. Obviously, GRS1189 adhered well to fibronectin as well as to type I and IV 
collagen (Figure 7 in I). The negative controls (GRS71 and GRS1052) and GRS1226 did not bind to any ECM 
proteins tested. The results indicated that the adhesion of SpaFED pili to ECM proteins is attributed to the 
SpaF pilin subunit. 
We also investigated whether SpaFED pili could adhere to intestinal epithelial cells, which are often used as 
targets to assess the attachment and colonization of pathogenic and non-pathogenic bacteria (Štyriak et al., 
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2003; Rendón et al., 2007; Chagnot et al., 2012). GRS1189 exhibited pronounced adherence to HT-29 cells, 
while a relatively low level of adherence to Caco-2 cells was observed (Figure 8 in I). However, these levels 
of GRS1189 were markedly higher than those of GRS71 and GRS1052. Once again, the importance of the 
SpaF subunit in adhesion was demonstrated, as GRS1226 showed an evident reduction in adherence to these 
two cell lines.  
The adhesiveness to intestinal components of SpaFED pili, especially the SpaF subunit, might offer L. 
rhamnosus GG a longer residence time in the gut, if SpaFED pili were expressed in vivo. Moreover, with 
ECM-adhesive factors such as SpaCBA (Lebeer et al., 2012; Tripathi et al., 2013) and SpaFED pili, L. 
rhamnosus GG might outcompete pathogens for binding sites in the ECM if the epithelial layer is broken, and 
thus prevent infection. However, such a hypothesis needs further confirmation and future work is warranted 
to identify appropriate conditions for SpaFED pilus expression.  
5.4.2 Adhesion capacity of Lactobacillus ruminis (II, III) 
In the stable GIT, autochthonous bacteria are supposed to live and proliferate in the intestinal lumen (van der 
Waaij et al., 2005). Nevertheless, the adherence of these bacteria to host intestinal substrates, such as mucins, 
other proteins, or epithelial cells, is usually assessed to explain their persistent presence in the gut (Vélez et al., 
2007). Such adhesiveness of autochthonous bacteria conferred by surface structures such as pili denotes the 
potential to competitively inhibit or interfere with pathogen colonization.  
Considering intestinal colonization, adherence to mucus is regarded as an advantage for both gut-resident 
bacteria and pathogens, as mucus forms the first layer of the intestinal barrier. However, according to a pan-
genome analysis, L. ruminis genomes do not encode proteins that possess mucus-binding domains (Kant et al., 
2017). In line with this prediction, our experiments revealed that L. ruminis ATCC 25644 cannot bind to mucus, 
and neither can the lactococcal recombinant constructs GRS1224 and GRS1225 expressing LrpCBA or 
LrpΔCBA pili (data not shown). Therefore, as an autochthonous bacterial species, L. ruminis must have 
evolved to adhere to other intestinal substrates in order to achieve its lifelong colonization in the GIT.  
The lrpC gene, encoding the tip pilin LrpC in L. ruminis ATCC 25644, is predicted to encode a collagen-
binding domain (S2 Fig in II). Therefore, we investigated the binding abilities of this L. ruminis strain to 
collagen as well as to fibronectin, and tested the effects of LrpCBA pili and the LrpC subunit on ECM protein 
binding by using the lactococcal clones GRS1224 and GRS1225. Evidently, in comparison with the controls 
GRS71 and GRS1052, L. ruminis pronouncedly adhered to collagen, but at a much higher level to type I than 
to type IV (Figure 5A and B in II). Similarly, nisin-induced GRS1224 markedly bound to type I collagen, 
while much less to type IV collagen, but still significantly better than the controls. Without the tip pilin LrpC, 
the adherence of GRS1225 to both collagen types was reduced compared to GRS1224, but was still obviously 
better than that of the controls.  
Regarding fibronectin binding, the degree of adherence of each strain was analogous to that of type I collagen 
binding (Figure 5C in II). Specifically, L. ruminis itself was able to bind to fibronectin at a level similar to the 
binding to type I collagen. Again, GRS1224 strongly bound to fibronectin and a reduction in GRS1225 
adherence was observed. The obtained results undoubtedly proved that LrpCBA pili contributed at least partly 
to the ECM-binding activity of L. ruminis, in which LrpC subunit has an indispensable role. Noticeably, L. 
ruminis adhered less readily to ECM proteins than GRS1224 and GRS1225, which might reflect that pili in 
each L. ruminis bacterium were less numerous, as observed by TEM.  
We further tested whether other L. ruminis strains of different host origins share ECM-binding properties. In 
addition to ATCC 25644 used as a positive control, a newly isolated L. ruminis strain, GRL1172, and two 
bovine strains, ATCC 27780 and ATCC 27781, were assessed for their ECM-binding activities (Figure 7). All 
four strains had similar binding patterns, but with varying levels of efficiency: the binding level to fibronectin 
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was the highest for each strain, followed by type I collagen, with the lowest binding to type IV collagen (Figure 
7). The adherence of all the strains to any ECM component was significantly higher than the binding to BSA. 
The binding to fibronectin of GRL1172 and ATCC 27781 was the highest, while GRL1172 and ATCC 25644 
were the strongest binders to type I collagen. Among these strains, ATCC 27780 was the least adhesive strain 
to all tested ECM proteins. Since LrpCBA pili are essential in mediating the adherence of ATCC 25644 to 
ECM, we assume that the binding activities of the other three strains are also related to pili. In the genomes of 
both ATCC 27780 and ATCC 27781, at least one gene is predicted to encode a pilin protein that has a collagen-
binding domain (Kant et al., 2017). Given that the predicted LrpC pilins of GRL1172 and ATCC 25644 share 
high similarity in their primary structures (data not shown), and that a collagen-binding domain has been 
identified in the LrpC pilin of ATCC 25644 (II), GRL1172 most likely also has a collagen-binding domain in 
its LrpC pilin. Moreover, the presence of pili in GRL1172 was demonstrated by TEM (Figure 1B in III) and 
pilus operons in the two bovine strains were verified by PCR (our unpublished data). For these three strains, 
unveiling the role of pili in adherence requires further investigation.  
 
Figure 7. Adherence of L. ruminis to ECM proteins. Modified from Figure 2 in study III. 
Since binding to epithelial cells could facilitate L. ruminis colonization and promote bacteria–host interactions, 
we tested whether L. ruminis and the recombinant constructs GRS1224 and GRS1225 bind to intestinal 
epithelial cells. ATCC 25644 adhered to Caco-2 and HT-29 cells at levels similar to the intrinsic binding of L. 
lactis strains GRS71 and GRS1052 (Figure 6 in II). However, GRS1224 efficiently bound to these two 
intestinal cell lines, indicating that LrpCBA pili can increase the adherence of L. lactis. The important role of 
the LrpC subunit in binding was again demonstrated, as lower adherence was detected for GRS1225 (Figure 
6 in II). Similarly, all four L. ruminis strains bound weakly to Caco-2 (data not shown), but strongly to HT-29 
(Figure 3 in III). Nevertheless, the porcine isolate GRL1172 could not bind to the porcine intestinal cell line 
IPEC-1, and neither could the other strains (data not shown). The pronounced adherence to HT-29 of human 
L. ruminis may reflect the frequent detection of this bacterial species in the human colon (Tannock et al., 2000; 
Reuter, 2001). As the non-human-originating L. ruminis strains were able to bind to human intestinal HT-29 
cells and to human ECM proteins, host specificity of L. ruminis adherence was not seen in our current results. 
Host specificity is, however, difficult to investigate further due to the lack of available intestinal cells or 
proteins originating from animals. 
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5.5 Biofilm formation in L. ruminis (II) 
Pili are able to participate in biofilm formation, as has been demonstrated with many Gram-positive bacteria 
(Mandlik et al., 2008b), including L. rhamnosus GG, in which SpaCBA pili play a focal role in facilitating 
biofilm formation (Lebeer et al., 2012). Accordingly, we tested whether the LrpCBA pili in L. ruminis possess 
such a feature in vitro. In the experimental set-up, L. rhamnosus GG, the SpaCBA-expressing strain GRS1185, 
and the SpaC-deleted GRS1211 construct (von Ossowski et al., 2013) served as controls. L. rhamnosus GG 
efficiently formed biofilms in polystyrene microplate wells, and SpaCBA pili appeared to partly contribute to 
this activity in a SpaC (tip pilin) dependent manner: the SpaC-deleted strain GRS1211 exhibited a substantial 
decrease in biofilm formation (Figure 7 in II). Similarly, L. ruminis ATCC 25644 had the capacity to form 
biofilms, whereas LrpCBA-piliated GRS1224 and GRS1225 failed to do so (Figure 7 in II). Therefore, we 
concluded that LrpCBA pili were not associated with biofilm formation in ATCC 25644. In the same way, the 
recombinant SpaFED pili did not participate in the biofilm formation of L. rhamnosus GG, either, as it was 
observed that the SpaFED-piliated strains GRS1189 and GRS1226 could not produce a biofilm. In fact, the 
obtained results are in line with the current knowledge that in Lactobacillus species, the involvement of pili in 
biofilm development is uncommon (Lebeer et al., 2012).  
5.6 Pathogen inhibition by L. ruminis (III) 
Members of the human gut microbiota exhibit pathogen inhibition by various mechanisms, including 
competition for common binding sites and nutrients, and the secretion of inhibitory factors (Todoriki et al., 
2001; Kamada et al., 2013). As a gut-dwelling species, L. ruminis might have the potential to inhibit the 
adhesion and growth of enteropathogens. To prove this hypothesis, we first assessed the inhibitory effects of 
four L. ruminis strains on pathogen adhesion using three inhibition assays (competition, exclusion and 
displacement), with ECM proteins and intestinal epithelial cells as binding targets. We first found that Yersinia 
enterocolitica DSM 13030 can bind to fibronectin and type I collagen, and a F4-fimbriated ETEC strain was 
found to adhere to type I collagen. Thus, these two strains were used as target pathogens. We then assessed 
the ability of L. ruminis to inhibit their adherence to these ECM proteins. Competition and exclusion assays 
indicated that all the L. ruminis strains evidently inhibited the adhesion of both pathogens to varying degrees 
(Figure 8). Nevertheless, in exclusion assays, except for ATCC 25644, the inhibitory rates of Yersinia binding 
to type I collagen conferred by the strains decreased by about 15–20% when compared to the inhibition rates 
of fibronectin binding. 
Subsequently, we investigated the inhibition abilities in intestinal epithelial cell models, including IPEC-1 and 
Caco-2, representing porcine and human small intestinal epithelial cells, respectively, even though all the L. 
ruminis strains poorly bound to these two cell lines. In line with previous studies demonstrating that poorly 
adhesive lactobacilli can still reduce pathogen adhesion (Tuomola et al., 1999; Gueimonde et al., 2006), all the 
L. ruminis strains clearly reduced the adherence of ETEC to IPEC-1 cells in competition and exclusion assays, 
while ATCC 27780 and ATCC 27781 showed slightly lower inhibitory rates in exclusion assays than in 
competition assays (Figure 5A and B in III). All the strains inhibited the adherence of S. typhimurium, Yersinia, 
and ETEC to Caco-2 cells at levels of around 20–50% in competition and 20–45% in exclusion assays (Figure 
6A and B in III). Additionally, although the adhesion rates of ATCC 27780 to fibronectin and type I collagen 
were the lowest of all the L. ruminis strains, the inhibition of pathogen adherence to the same substrates by 
ATCC 27780 was as efficient as the inhibition caused by the other strains. Therefore, it appears that the 
inhibition of pathogen adherence is not associated with the adhesiveness of L. ruminis. Indeed, apart from 
competition for common binding sites, other factors, such as coaggregation with pathogens and the excretion 
of inhibitory compounds, can also inhibit pathogen adherence (Lebeer et al., 2008). However, evident 
coaggregation between L. ruminis and pathogens was not observed in vitro in the present study (results not 
shown). 
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Generally, studies on pathogen displacement by lactobacilli are scarce. The few studies available have shown 
that lactobacilli either fail to displace pre-adherent pathogens from host substances or generate much lower 
degrees of inhibition compared to competition or exclusion assays (Lee et al., 2003; Gueimonde et al., 2006). 
Accordingly, our results revealed that all the L. ruminis strains failed to displace previously adhered pathogens 
from fibronectin and type I collagen (Figure 8). Surprisingly, all the strains did, however, displace previously 
adhered S. typhimurium (inhibition of 20–30%), but not Y. enterocolitica or ETEC from Caco-2 cells (Figure 
6C in III). Our results were in line with one previous study showing that the pathogen displacement efficiencies 
of lactobacilli are dependent on the pathogen strains used (Lee et al., 2003).  
 
The culture supernatants of the four L. ruminis strains inhibited the growth of six selected enteropathogens. 
The inhibition of ETEC growth was the strongest, with an approximately 1000-fold reduction (Figure 7 in III). 
The growth inhibition of other pathogens was decreased by about 10- to 100-fold. Notably, the growth 
inhibition was largely attributed to the pH of the supernatant, as the inhibition caused by the supernatant from 
ATCC 27780 with the lowest pH of 4.13 was the most efficient, while the supernatant from GRL1172 with 
the highest pH of 4.34 was the least efficient. Moreover, after adjusting the supernatants to the pH of plain 
MRS medium, a less than 10-fold reduction in pathogen growth was detected, confirming that the dominant 
contributors to growth inhibition were acids produced during fermentation. Lactic acid is apparently the 
principal factor, as L. ruminis is regarded as a homofermentative species (Kanlder and Weiss, 1986), although 
a recent publication suggested that it may also use heterofermentative pathways to widen its repertoire of 
energy sources (Kant et al., 2017). Apart from lowering the pH, lactic acid could also permeabilize the outer 
membrane of Gram-negative bacteria and thus improve the efficiency of other antimicrobial substances 
(Alakomi et al., 2000). In accordance with our results, many other lactobacilli originating from humans and 
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animals are able to inhibit the growth of intestinal pathogens due to the acidic environment they create (Annuk 
et al., 2003; Lähteinen et al., 2010). In addition to acids, other metabolites produced by lactobacilli, such as 
hydrogen peroxide, carbon dioxide, diacetyl, and bacteriocins, have antimicrobial effects (Ouwehand and 
Vesterlund, 2004). Genes encoding bacteriocins have been identified in the genomes of human L. ruminis 
ATCC 25644 and the bovine L. ruminis strain ATCC 27782 (Forde et al., 2011), but their presence in other L. 
ruminis strains and their expression in vitro require further investigation.  
5.7 Immunomodulatory effects of L. rhamnosus GG and L. ruminis (I, II, III) 
The host immune system mounts efficient protective immune responses against pathogens and exhibits 
tolerance to the diverse gut-dwelling microbes (Artis, 2008). For either immune tolerance or protective defense, 
the interactions between MAMPs and PRRs on epithelial or immune-related cells are of great importance. In 
Lactobacillus, cell surface components, including LTA, lipoproteins, lipopeptides, flagella (Wells, 2011), S-
layers (Konstantinov et al., 2008; Hynönen et al., 2014), and SpaCBA pili in L. rhamnosus GG (Lebeer et al., 
2012; von Ossowski et al., 2013), are able to activate innate immunity. In this study, we assessed the 
immunomodulatory effects of L. rhamnosus GG SpaFED pili and L. ruminis LrpCBA pili. 
5.7.1 Immuno-characteristics of L. rhamnosus GG SpaFED pili (I) 
Previously, it was reported that L. rhamnosus GG SpaCBA pili expressed in lactococci interact with the innate 
immune system (von Ossowski et al., 2013). SpaCBA pili, functioning as one type of MAMPs, were 
recognized by TLR2 and thus elicited NF-κB signaling as well as IL-8 production in HEK-TLR2 cells. 
Additionally, SpaCBA pili activated pro- and anti-inflammatory cytokine production in human-derived 
moDCs. Importantly, the tip pilin SpaC was essential in the above immune responses. To investigate whether 
L. rhamnosus GG SpaFED pili have similar effects, we tested the immuno-characteristics of GRS1189 and 
GRS1226 with the same methodology as used for SpaCBA pili. GRS71 and GRS1052, used as controls, 
induced marked NF-κB activation in HEK293-TLR2 cells, whereas GRS1189 evoked such a reaction at a level 
much lower than the controls (Figure 9 in I). However, GRS1226 lacking the tip pilin SpaF promoted NF-κB 
activation to a similar degree as the controls (Figure 9 in I). The results here suggested that the SpaFED pili 
appeared to hinder TLR2-dependent NF-κB signaling activated by L. lactis, in which the SpaF subunit 
appeared to have a determining role. To test whether such immune responses are activated by proteinaceous 
components, the above experiment was performed with the aforementioned lactococci that were treated by 
heat. After exposure to a protein-denaturing temperature, all the lactococcal strains almost failed to induce NF-
κB activation (Figure 9 in I), suggesting that heat-labile proteins were implicated in the immunostimulating 
effect. Moreover, to determine whether such immune responses were triggered by direct contact between 
bacterial surface-associated proteins, Transwell cell culture membrane inserts with a 0.4-μm pore size were 
used to separate HEK-TLR2 cells from the lactococcal strains. Without cell-to-cell contact, NF-ĸB activation 
was eliminated, which also indicated that the proteinaceous stimuli were either attached to or released from 
the bacteria but could not go through the membrane (Figure 10 in I). 
Furthermore, the immune-dampening effect caused by SpaFED pili was also observed in intestinal Caco-2 
cells. Compared to GRS1052, GRS1189 generated lower IL-8 production, whereas GRS1226 was as efficient 
as GRS1052 (Figure 11 in I). In contrast, as shown in Figure 12 in study I, GRS1189 no longer dampened the 
production of pro- and anti-inflammatory cytokines (TNF-α, IL-12 and IL-10) in moDCs, nor promoted these 
immune reactions like SpaCBA pili (von Ossowski et al., 2013). Since the moDCs were isolated from 
peripheral blood, we presumed that such immune responses might not fully reflect the bacteria–host cell 
interactions in the gut. If SpaFED pili are expressed in vivo, their immuno-dampening effects may represent 
adaptation to the host gut, counteracting the SpaCBA pili-induced immune responses, to achieve immune 
homeostasis. 
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5.7.2 Immuno-characteristics of L. ruminis (II, III) 
Firstly, HEK-TLR2 cells were used to assess the immune stimulation profile of L. ruminis ATCC 25644 and 
its LrpCBA pili displayed on L. lactis. L. ruminis evoked pronounced levels of NF-κB activation and IL-8 
production in HEK-TLR2 cells. This activation was slightly decreased when L. ruminis was treated with a 
protein-denaturing high temperature (Figure 8 in II), but largely and more pronouncedly decreased (though 
still measurable) when L. ruminis was segregated from HEK-TLR2 cells (Figure 9 in II). The results here 
indicated that the immunomodulatory effects of L. ruminis were partly related to its heat-labile proteins, which 
were either anchored to the cell surface or could not pass through the insert membrane if secreted or detached. 
However, GRS1224 and GRS1225 expressing LrpCBA or LrpΔCBA pili induced much lower immune 
responses than did L. ruminis and the controls, GRS71 and GRS1052 (Figure 8 in II). Similarly to L. rhamnosus 
GG SpaFED pili, we assumed that LrpCBA pili also dampened the immune responses elicited by L. lactis, but 
tip pilin LrpC did not have an essential role. When GRS71, GRS1052, GRS1224, and GRS1225 were treated 
with a high temperature and separated from HEK-TLR2 cells, these immune reactions were almost abolished 
(Figure 8 and 9 in II), which then again confirmed that the bacterial stimuli were heat-labile and were either 
attached to the cell surface or secreted but could not pass through the membrane.  
Analogous experiments were performed with three other different-sourced L. ruminis strains, with the human 
strain ATCC 25644 used as a control. All the strains induced NF-κB activation and IL-8 production in HEK-
TLR2 cells to varying degrees (Figure 10 in III and Table 6). Among them, the two bovine strains generated 
relatively low levels of these immune activities. After being inactivated by high temperature, all strains except 
the human isolate almost completely failed to evoke immune responses. Unanimously, all the strains 
partitioned from HEK-TLR2 cells by Transwell inserts no longer stimulated immune activities. However, we 
observed that the culture supernatants of the four L. ruminis strains retained the immunostimulatory effects 
(Figure 11 in III). Therefore, we assumed that some released cell surface components present in the spent 
culture supernatant, but not able to penetrate the Transwell insert membrane, such as LTA and lipoproteins, 
were involved, as demonstrated by other studies (Jones et al., 2005; Henneke et al., 2008). When the culture 
supernatant was treated with a high temperature, NF-κB activation was only partly affected, displaying a slight 
reduction, whereas IL-8 production was markedly reduced (Figure 11 in III). This suggested that some secreted 
or detached heat-resistant substances were associated with TLR2-dependent signaling.  
Table 6. NF-κB signaling induced by L. ruminis in HEK-TLR2 and HEK-TLR5 cells 
 
Strain or control 
Efficiency of induction* 
HEK-TLR2 HEK-TLR5 
 Heat treatment  Heat treatment 
GRL1172 5.0±0.2*** 1.3±0.1 12.2±2.6*** 8.9±1.2 
ATCC 25644 5.6±0.5*** 2.0±0.2 6.2±1.8*** 0.9±0.1 
ATCC 27880 4.0±0.5*** 1.6±0.0 11.6±2.4*** 1.1±0.1 
ATCC 27781 3.9±0.4*** 1.0±0.1 12.2±2.4*** 5.0±1.9 
Medium 1 1 1 1 
*Efficiencies are expressed as relative values of NF-κB activation compared to the induction caused by the 
growth medium. Pairwise comparisons between samples with or without heat treatment were shown as: 
***P≤0.0001 (extremely significant).  
In addition, to study TLR5 ligands in L. ruminis, we also tested whether L. ruminis could activate TLR5 
signaling. L. ruminis is so far the only motile Lactobacillus species that is known to be an autochthonous 
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member in the mammalian gut microbiota (Neville et al., 2012). We utilized HEK-TLR5 cells to confirm the 
expression of flagella-encoding genes in this strain, as well as in the other three L. ruminis isolates, as flagellins 
appear to be the only ligands that induce TLR5 signaling (Hayashi et al., 2001). All four strains, after growing 
on MRS agar plates for 2 days (based on our preliminary experiments, flagella in L. ruminis are well expressed 
under these conditions), elicited conspicuous TLR5-dependent NF-κB activation (Figure 12A in III and Table 
6), suggesting that in these strains, flagellar proteins were produced. Nevertheless, compared to the other three 
strains, ATCC 25644 induced considerably lower IL-8 production (Figure 12B in III). After high-temperature 
treatment, ATCC 25644 and ATCC 27780 totally failed to induce NF-κB signaling, but the other two L. 
ruminis strains still had immunostimulatory properties. Therefore, we speculated that the flagellins of 
GRL1172 and ATCC 27781 were more heat resistant, but the underlying mechanism is unknown. Separation 
from HEK-TLR5 cells did not affect NF-κB activation and IL-8 production induced by GRL1172 and ATCC 
27781, while it lowered the NF-κB and IL-8-inducing activities of ATCC 25644 and ATCC 27780. It is 
reasonable to propose that flagellins or broken flagella can pass through the insert membrane with a pore size 
of 0.4 μm, since 0.2 μm pore-sized filters cannot prevent the passing of flagellins (Gewirtz et al., 2001b). It 
appeared that flagella in GRL1172 and ATCC 27781 were more likely to be detached, or these bacterial cells 
were more prone to be broken, thus resulting in more flagellins being released and correspondingly higher 
TLR5-dependent immune responses. Interestingly, GRL1172 and the two bovine strains elicited NF-κB 
activation to similar degrees, but varying IL-8 induction levels. Since flagellins are also able to promote the 
production of IL-8 through the TLR5-p38 MAPK signaling pathway, which is independent of the NF-κB route 
(Yu et al., 2003; Gewirtz et al., 2004), we assumed that these three strains had varying capabilities to activate 
the p38 route, thus resulting in varying IL-8 levels. It has also been reported that amino acid sequence variations 
in the structural domains of flagellin may account for differences in IL-8 secretion (Verma et al., 2005; Im et 
al., 2009); this finding may apply to L. ruminis flagellins as well. 
Additionally, intestinal Caco-2 cells and moDCs were used to assess the immunomodulatory effects of L. 
ruminis ATCC 25644 and its LrpCBA pili. In Caco-2 cells, LrpCBA-expressing GRS1224 and GRS1225 
constructs induced the production of IL-8 to a similar extent, but mildly lower compared to the controls GRS71 
and GRS1052 (Figure 10 in II), indicating that LrpCBA pili have a dampening effect and the LrpC subunit is 
not the determining factor. Similar results were observed in HEK-TLR2 cells (Figures 8 and 9 in II). L. ruminis 
ATCC 25644 itself induced the lowest IL-8 secretion among all the strains, being at a level equivalent to the 
DMEM medium control (Figure 10 in II), indicating that other factors in L. ruminis, in addition to pili, dampen 
the IL-8 response. It is conceivable that host cells are tolerant to autochthonous L. ruminis cells in order to 
maintain gut homeostasis, which in return is also beneficial for the persistent residence of this bacterial species. 
Conversely, in HEK-TLR2 cells, L. ruminis ATCC 25644 efficiently evoked IL-8 secretion, and we speculate 
the following: Given that TLR2 is expressed on the basolateral membrane of IECs (Peterson and Artis, 2014), 
L. ruminis colonizing the mucosal layer under healthy conditions is not thought to induce TLR2-mediated pro-
inflammatory responses through this receptor, which may partly explain the different immune behavior of L. 
ruminis in HEK-TLR2 (artificial cells overexpressing TLR2) and Caco-2 cells.  
Subsequently, we noticed that all the lactococcal strains elicited almost similar degrees of TNF-α and IL-12 
secretion in moDCs, which were lower than those induced by L. ruminis ATCC 25644 (S5 Figure in II). The 
result was in line with the observations with SpaFED pili in a similar experimental set-up (the first study in 
this work). The data here revealed that other MAMPs of L. ruminis rather than LrpCBA pili were engaged in 
the elevated production of inflammatory cytokines by in moDCs. Indigenous bacteria in the GIT are recognized 
by host innate cells (e.g., DCs) under normal circumstances, which activates the production of inflammatory 
cytokines in vivo, but still maintaining gut homeostasis (Rakoff-Nahoum et al., 2004). In this way, 
hypothetically, with the ability to stimulate moDCs, L. ruminis might contribute to gut homeostasis. However, 
the immune responses induced by indigenous bacteria are regulated and balanced, exhibiting an immune to 
tolerant state. Otherwise, this microbe–host interaction would result in detrimental effects. 
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5.8 Effects of L. ruminis on intestinal barrier function (III) 
Intestinal epithelial cells are interconnected by junctions such as TJ protein complexes that are indispensable 
in the maintenance of barrier integrity. Confronting enteropathogens may result in changes in TJ protein 
distribution, thus leading to augmentation of permeability. It has been reported that several members of the gut 
microbiota of humans, pigs, and canines, such as L. plantarum (Qin et al., 2009), L. acidophilus (Kainulainen 
et al., 2015), and L. amylovorus (Roselli et al., 2016), are able to increase the TEER values and TJ protein 
expression, prevent pathogen-caused barrier damage, and thus preserve an intact epithelial layer. Therefore, to 
determine whether L. ruminis can affect intestinal barrier function in vitro, we exposed Caco-2 cells, grown 
on tissue-culture inserts, to four L. ruminis strains alone or with ETEC and measured changes in TEER values 
(Figure 9), dextran diffusion (Figure 8B in III), and the location of TJ proteins (Figure 9 in III). During the 
three-day measurement, TEER values were slightly decreased when Caco-2 cells were incubated with the cell 
culture medium alone, whereas the values dropped to about 15% of the original levels 24 h after the addition 
of ETEC (Figure 9). Conversely, all the four L. ruminis strains increased TEER values during the experimental 
period, though fluctuations were observed (Figure 9).  
 
Figure 9. Changes of TEER values in Caco-2 induced by L. ruminis and ETEC. Modified from Figure 8A 
in study III. 
Dextran, incubated on Caco-2 cells in the cell culture medium with or without L. ruminis cells, cannot diffuse 
through the epithelium. However, the addition of ETEC alone or with L. ruminis strains to the cell culture 
medium largely induced dextran diffusion. These results indicated that L. ruminis fortifies the barrier, but 
cannot inhibit barrier defects caused by ETEC, which was further confirmed by immunofluorescence assays 
locating TJ proteins. In these assays, clear and continuous lines were seen around each Caco-2 cell when they 
were exposed to the L. ruminis strains and the detection was performed with antibodies against TJ proteins 
(ZO-1, claudin-4, and occludin) (Figure 9A in III). In contrast, blurry cell boundaries, scattered fluorescent 
spots, or even visible holes appeared in Caco-2 cells incubated with ETEC alone or with ETEC and L. ruminis 
strains (Figure 9A and B in III), indicating that these TJ proteins were dislocated and the epithelial barrier was 
disrupted. Our results demonstrate that L. ruminis, as an autochthonous bacterial species in the gut, can 
maintain the epithelial barrier, which reflects the role of gut microbiota in maintaining host intestinal health.  
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6. Conclusions and future perspectives 
The gut microbiota peacefully exists in the host GIT under healthy conditions, which is attributed to various 
niche-adaptation factors. In this study, L. rhamnosus GG and L. ruminis, respectively representing an 
allochthonous and an autochthonous member of the gut microbiota, were used as paradigms to investigate the 
gut-adaptive traits of intestinal bacteria.  
In the first study, the L. rhamnosus GG SpaFED pili recombinantly expressed on L. lactis were characterized. 
SpaFED pili exhibited adhesive properties to mucin, ECM components, and intestinal epithelial cells (Caco-2 
and HT-29), and the tip pilin SpaF was shown to be the essential adhesive factor. Therefore, in addition to the 
adhesive SpaCBA pili (von Ossowski et al., 2013), SpaFED pili might also contribute to the prolongation of 
the gut retention time of allochthonous L. rhamnosus GG. Moreover, SpaFED pili dampened the innate 
immune responses that were activated by L. lactis in HEK-TLR2 cells. This was completely opposite to the 
outcome seen with L. rhamnosus GG SpaCBA pili, which elevated NF-κB activation and IL-8 production (von 
Ossowski et al., 2013). In the gut environment, if SpaFED pili were expressed, their dampening effects might 
balance the immune responses induced by SpaCBA pili to maintain immune homeostasis. A pan-genomic 
study demonstrated the presence of the spaFED operon in all 13 of the L. rhamnosus strains studied, and it 
was thus considered as belonging to the core genome, whereas the spaCBA operon was only shared by four 
strains, and it was correspondingly excluded from the core genome (Kant et al., 2014). Additionally, the 
spaFED operon was also identified in the genomes of L. casei and L. paracasei (Muñoz-Provencio et al., 2012; 
Smokvina et al., 2013). Nevertheless, native SpaFED pili have not been proved to be present on any of these 
Lactobacillus strains under the experimental conditions used. However, we assume that spaFED operon might 
be expressed in vivo only in the host GIT, like the bifidobacterial Tad pilus genes (Motherway et al., 2011). 
To test this hypothesis, germfree mice could be fed with adequate numbers of L. rhamnosus GG cells, and 
intestinal extracts could be collected to determine SpaFED pilus expression by performing Western blotting 
or immuno-TEM at different time points after inoculation. If SpaFED pili were successfully detected by these 
proposed methods, derivatives of L. rhamnosus GG without SpaFED pili could be constructed to verify the 
observed properties of SpaFED pili in vitro, such as adhesiveness and immune dampening, to further 
investigate the functional characteristics of SpaFED pili in vivo. 
In study II, a novel pilus type was identified in the gut-autochthonous species L. ruminis. LrpCBA pili in L. 
ruminis ATCC 25644, and especially the tip pilin LrpC, contributed to L. ruminis adherence to ECM proteins 
and intestinal epithelial cells, as demonstrated by the lactococcal expression system. However, neither L. 
ruminis nor L. lactis expressing LrpCBA pili bound to mucin. Presumably, L. ruminis can penetrate the mucus 
and reside closely to the epithelial cells. In addition to acting as an adhesive factor that may facilitate gut 
colonization, LrpCBA pili, when displayed on L. lactis, also had a dampening effect on L. lactis-induced NF-
κB signaling in HEK-TLR2 cells and on IL-8 production in Caco-2 cells. These results suggest that LrpCBA 
pili might partly explain the immune tolerance of the host to L. ruminis, which thus indirectly contributes to 
the gut indigeneity of L. ruminis. Conversely, whole L. ruminis cells pronouncedly activated TLR2-dependent 
signaling in HEK-TLR2 cells, which indicated that other cell surface structures in L. ruminis, such as LTA and 
lipoproteins, are involved in immunomodulation. This, however, remains to be investigated. L. ruminis did not 
show any immunostimulatory effects when exposed to Caco-2 cells, thus suggesting that the host cells have 
evolved to tolerate the gut autochthonous species, which has also developed to not induce elimination by the 
host. However, in vivo studies are needed to characterize the roles of LrpCBA pili in the interactions between 
L. ruminis and the host GIT in more detail. To do this, the expression of LrpCBA pili in vivo could be 
investigated. Subsequently, the role of LrpCBA pili in L. ruminis gut colonization and immunomodulation 
could be evaluated by comparisons between L. ruminis and its mutants lacking LrpCBA pili or specific pilins. 
Meanwhile, other factors that contribute to the gut indigeneity of L. ruminis are worth exploring in the future.  
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In study III, a novel L. ruminis strain was isolated from porcine feces and was demonstrated by TEM to be 
piliated and flagellated. Some common features were observed in different L. ruminis strains by analyzing the 
functional characteristics of this new strain together with three other L. ruminis strains (one human and two 
bovine isolates). None of the strains could bind to mucin, but they bound to ECM components and to HT-29 
cells, suggesting that L. ruminis may reside near the epithelial layer. Moreover, all the strains inhibited 
pathogen growth and adherence to host surfaces, including intestinal epithelial cells (Caco-2 and IPEC-1) and 
ECM proteins. Such properties can not only protect the host from pathogen infection, but also contribute to 
the long-term colonization of L. ruminis. Notably, even though the binding of these four L. ruminis strains to 
Caco-2 and IPEC-1 was poor, they conferred inhibition of pathogen colonization. On the grounds of this, it 
appears obvious that mechanisms other than competitive adherence are involved, which requires further 
investigation. Additionally, when incubated on Caco-2 cells, all the strains increased the TEER value, 
prevented dextran diffusion and maintained the location of TJ proteins, which supported the epithelial barrier 
functions of Caco-2 cells. This phenomenon can be regarded as an advantage to the host and it thus partly 
contributes to the gut indigeneity of L. ruminis. Furthermore, these strains evoked innate immune responses, 
including NF-κB activation and IL-8 production, in HEK-TLR2/TLR5 cells. The mucosal immune system 
exhibits tolerance to the indigenous microbes, and how the immunomodulatory L. ruminis and the host 
maintain the homeostasis therefore needs to be investigated in the future. Since flagellin, based on current 
knowledge, is the only known ligand for TLR5, the activation of TLR5 signaling thus indicates that in addition 
to the porcine isolate, the human and bovine L. ruminis are also flagellated. Of the gut indigenous lactobacilli, 
L. ruminis is currently considered as the only motile species (Neville et al., 2012). Flagella can propel L. 
ruminis through the mucus to reach nutrient-rich niches and facilitate colonization in the gut. However, in vivo 
studies are still required to determine whether the above traits can be detected in the host GIT and whether 
they contribute to the autochthony of L. ruminis, as well as to investigate the location of L. ruminis in the GIT.    
Due to the potential gut autochthonicity-promoting factors (e.g. adhesiveness) and several interesting effects 
that L. ruminis may confer to the host, such as immunostimulation and pathogen inhibition, L. ruminis might 
be a candidate probiotic for humans and animals in the future. Even though some L. ruminis strains have been 
reported to be susceptible to gastric and bile acids (O’Donnell et al., 2015), they might survive in the GIT if 
delivered in enterocapsules or in other forms that delay their release in the GIT. The combination of several 
beneficial strains appears to be a trend for probiotic products, but whether L. ruminis has antagonistic effects 
on other probiotic strains should be explored if L. ruminis is to be considered as a probiotic in the future. Many 
Lactococcus and several Lactobacillus strains have been extensively studied as carriers for mucosal 
vaccination, due to features such as safety, adhesiveness, and abilities to boost immune responses (Wyszyńska 
et al., 2015), in a manner similar to adjuvants. Therefore, L. ruminis strains might also be considered as novel 
vaccine carriers, for the following reasons: (1) L. ruminis is a member of the genus Lactobacillus and an 
autochthonous species in the GIT, so it is regarded to be safe to the host; (2) since it is flagellated and piliated, 
L. ruminis could get closer to the intestinal epithelium, colonize it, and promote host–antigen interactions. 
These speculative applications are worth further investigation.   
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